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 Although largely considered an environmental pathogen given its ability to infect insects 
and survive in nature, Serratia marcescens is an important cause of multi-drug resistant 
bloodstream infections with increasing prevalence. With its current status as an emerging 
pathogen, little is known about factors contributing to S. marcescens infection specifically 
regarding those that aid in iron acquisition. Iron uptake is well established in the field as being 
crucial for bacterial colonization and pathogenesis since it is an essential protein co-factor in 
many cellular functions. However, mammalian hosts tightly regulate iron, making it difficult for 
pathogens to access. Therefore, bacteria employ specialized systems to gather iron, including the 
use of siderophores, heme uptake, ferrous iron receptors, and others. The overarching goal of this 
dissertation was to comprehensively characterize the iron-uptake systems in a bloodstream 
isolate of S. marcescens, UMH9. In Chapter II, iron-depleted RNA-sequencing was used to 
identify all the genes regulated by iron concentration in UMH9. Through these experiments, I 
identified seven independent iron acquisition systems, including two siderophore loci and two 
previously described heme uptake systems. Seven additional orphan transporters were also 
identified. Further studies in this dissertation focused on characterizing the siderophore and heme 
uptake loci. 
 In Chapters III and IV, I describe my work characterizing the two siderophore systems, 
cbs and sch, identified by RNA-seq in UMH9 and named after previously described siderophore 
loci to which they have similarity. In Chapter III, deletions were made in the non-ribosomal 
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peptide synthetase (NRPS) machinery in each siderophore locus as well as together in a double 
mutant. In vitro growth in iron-poor conditions revealed that the double NRPS mutant in both 
siderophore loci had defective growth, but still produced siderophore by chrome azurol S (CAS) 
and mass spectrometry. The single NRPS mutants behaved similarly to the wild type strain, 
suggesting that the deleted NRPS genes potentially have redundant roles in siderophore 
transport. These findings challenge the traditional exclusive role of NRPSs in siderophore 
biosynthesis. Chapter IV examines the siderophores from a pathogenesis perspective. Mutations 
were made deleting the entire siderophore loci individually and in combination. Mutants lacking 
the full sch locus lost their ability to chelate iron as quantified by the CAS assay, while the cbs 
single mutant retained wild-type activity. Using mass spectrometry, the chelating siderophore 
was found to be serratiochelin (sch) while the other was chrysobactin (cbs). Sch-mutants had 
defective growth in iron-limited conditions and deletion of the sch gene cluster resulted in 
attenuation of UMH9 in the mouse bacteria model. Therefore, serratiochelin is necessary for full 
virulence during bloodstream infection. Chapter V examines the S. marcescens heme uptake 
systems, hem and has. Deletion mutants were made in each system individually and together in a 
double mutant. Growth conditions supplemented with heme revealed that mutants with intact 
hem system experienced an abnormally long lag phase before reaching exponential growth and 
saturation. This suggests that the hem system may contribute to heme toxicity. Whole genome 
sequencing revealed new insights into potential heme detoxification mechanisms. Interestingly, 
the double heme uptake mutant did not display any in vivo fitness defects or attenuation, 
suggesting a nonsignificant contribution of heme uptake to UMH9 pathogenesis during 
bacteremia. Altogether, these studies provide an in-depth characterization of two major classes of 
iron acquisition, siderophore and heme uptake, and their contribution to pathogenesis in Serratia 
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marcescens. This work challenges canonical understandings of Gram-negative iron acquisition 




An Introduction to Bacterial Iron Acquisition and Serratia marcescens
 
Notes. A portion of this chapter was published in the Encyclopedia of Microbiology:  
 
Weakland DR, and Hammer ND. Bacterial Iron Acquisition Strategies. Editor: Thomas M. 
Schmidt, Encyclopedia of Microbiology, Ed. 4. Academic Press-Elsevier, 2019, Pg. 410-417. 
 
This chapter provides a review of the literature describing what is known in the field of bacterial 
iron acquisition more generally pertaining to Gram-negative microbes, and then specifically 
focusing on iron systems in Serratia marcescens, the bacterium of interest for the remainder of 
this dissertation excluding Appendix C.    
 
Iron: why it’s important 
Iron is a fundamental building block for life. The dynamic oxidation states of this 
transition metal are required for the catalysis of many essential biochemical reactions. Consistent 
with this, iron typically exists in the ferric (+3) state or ferrous (+2) oxidation states. However, 
the ease with which iron transitions between these oxidation states and its low solubility at 
neutral pH are two problems organisms must solve. The solution is to complex iron within 
cofactors or bound to proteins. Thus, this highly reactive atom is rarely “freely” available to react 
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with sensitive molecules within organisms. Iron-containing cofactors and proteins allow cells to 
harness the chemical dynamism of iron without the associated toxicity or insolubility. Numerous 
chemical reactions involved in central metabolism, nucleotide synthesis, and the detoxification 
of reactive oxygen and nitrogen species are catalyzed by enzymes that contain one or more iron 
atom, highlighting the essentiality of iron to cellular physiology.  
In eukaryotes, an additional benefit of maintaining low levels of “free” iron is the 
challenge that the limitation imposes on invading bacterial pathogens. Most pathogens, like their 
hosts, require iron to perform essential biochemical reactions, but pathogens are completely 
dependent on sources of iron present within the host environment to fulfill this requirement. The 
host exploits this requirement and utilizes multiple mechanisms to impede pathogen iron 
procurement. The process of inhibiting the proliferation of invading bacteria by obstructing 
access to essential nutrients, such as iron, is called “nutritional immunity” [1, 2]. To overcome 
nutritional immunity, bacterial pathogens have evolved sophisticated systems to procure iron 
from the host environment.  
 
Iron sources in the host 
Low solubility at physiological pH and a high propensity for oxidation necessitates that 
iron be complexed to another molecule. Numerous, iron-binding molecules present in the host 
achieve this goal. In vertebrates, iron is predominantly bound to proteins or the tetrapyrrole 
heme. Iron-binding and heme-binding proteins also function to impair the availability of iron 
from invading pathogens. Additionally, iron is principally contained within host cells, further 
obstructing the accessibility of this metal to invading pathogens. Extracellular iron is bound by 
high-affinity iron-binding proteins such as ferritin, transferrin, and lactoferrin [3]. Extracellular 
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heme is sequestered by hemopexin [4]. Together, these mechanisms of iron sequestration ensure 
that the host environment is a “free” iron-deplete environment. These iron-binding proteins act as 
additional barriers to pathogen iron acquisition. However, pathogens have evolved elegant 
systems to extract iron from these proteins.  
The most abundant iron-containing molecule in vertebrates is the tetrapyrrole heme. 
Consequently, many pathogens encode heme acquisition systems to steal heme-iron from the 
host. Heme is predominantly complexed to the protein, hemoglobin within erythrocytes. In this 
context, heme functions to transport oxygen to, and carbon dioxide away from host tissues. 
Consistent with this, erythrocyte lysis is a virulence trait associated with many bacterial 
pathogens, and this trait functions to liberate a great deal of iron in the form of heme-bound 
hemoglobin [5]. However, through the Fenton reaction, iron can yield highly reactive hydroxyl 
radicals, which are toxic at high concentrations; therefore, the systems that function to scavenge 
iron or heme from the host environment are under strict transcriptional control. As such, 
pathogens express iron acquisition systems only when the cell resides within iron depleted 
environments. In most bacteria this transcriptional control is achieved by the ferric uptake 
regulator Fur (Figure 1.1) [6].   
 
Transcriptional control of iron acquisition systems 
Despite the abundance of iron within vertebrates, iron-binding proteins and the vast 
intracellular reservoirs are not readily available to invading pathogens. Therefore, upon breach of 
protective barriers and invasion into tissues the pathogen enters an iron-deplete environment. 
Concomitantly, the microbial invaders upregulate genes encoding iron acquisition systems. Fur 
(monomer molecular weight: 17-21 kDa) is the master transcriptional regulator of iron 
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acquisition systems and Fur-dependent transcriptional control is achieved via a canonical 
mechanism of repression (Figure 1.1) [7]. Within the bacterial cytoplasm, Fur dimerizes and 
binds excess iron. It then represses the expression of iron acquisition systems. Repression of 
target transcripts is mediated by the high affinity of ferric iron-bound Fur for consensus DNA 
sequences present within the promoter sequences of genes encoding iron acquisition systems. 
Fur binding blocks RNA polymerase, resulting in transcriptional repression. When iron becomes 
limiting, the amount of intracellular iron decreases. This causes the release of iron from Fur and 
the DNA-binding affinity of Fur for the consensus sequence is significantly reduced [8]. 
Consequently, the freed target promoter is accessible to RNA polymerase that in turn transcribes 
iron acquisition genes. Fur is conserved in Gram-negative pathogens, and locating the Fur 
consensus sequences within bacterial genomes has led to the identification of many of the iron 
acquisition systems discussed below [6]. The importance of this transcriptional regulator is 
demonstrated by the profound virulence defects of fur mutants [9-12]. Additionally, Fur activity 
ensures that iron acquisition systems are expressed exclusively in iron-depleted environments. 
Unregulated expression of these systems is energetically costly to the bacterium in iron-replete 
conditions when iron import is not needed. Constitutive import of iron is also detrimental to 
bacterial cells as excessively high levels of iron can lead to production of damaging reactive 
oxygen species through the Fenton reaction. Therefore, while iron is crucial to bacterial survival, 





Figure 1.1. Iron uptake gene regulation by Fur. 
Iron systems are regulated by intracellular iron concentrations. In iron-poor conditions, uptake 
systems are highly expressed in order to import iron. However, when iron levels are sufficient, 
iron molecules bind the ferric uptake regulator (Fur), which then binds to Fur-box consensus 
sequences on the genome. The Fur-iron complex displaces RNA polymerase to repress iron-
uptake system gene expression. 
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Bacterial strategies to acquire iron  
Due to the aforementioned low levels of iron in the body, Gram-negative pathogens use several 
mechanisms to acquire iron. Because ferrous iron is soluble, bacterial transporters can easily take 
it up. Ferric iron is insoluble and requires active transport across bacterial membranes. Citrate 
can act as a low-affinity siderophore and bind ferric iron for import. However, bacteria primarily 
employ two mechanisms to acquire ferric iron, using siderophores and heme uptake. 
 
Iron acquisition via siderophores  
A major class of Fur-regulated genes encode enzymes that synthesize low molecular 
weight (500-1500 Da), ferrous iron-binding compounds called siderophores [13]. The high 
affinity siderophores have for iron allows these molecules to outcompete most host proteins for 
iron. For example, the ferric binding constants of siderophores is typically Kf > 10-30 M, with 
enterobactin having the highest reported affinity at 10-52 M. This is much greater than the binding 
constant of transferrin, 10-23 M [13, 14]. Siderophore-mediated iron acquisition is a common iron 
procurement strategy that is widely conserved among pathogenic and non-pathogenic bacteria 
but also fungi, yeast, and animals. Consistent with this, over 500 different siderophores have 
been described [15]. Often, different species of bacteria produce identical siderophores; however, 
some pathogens produce novel siderophores to prevent competing microbes from stealing their 
siderophore. In bacteria, the genes involved in siderophore biosynthesis and import are typically 
present within a single operon [16]. Specifically, these operons usually consist of biosynthesis 
enzymes, siderophore efflux pumps, siderophore-iron complex importers, and accessory proteins 
that aid in siderophore function. The operons present in Gram-negative bacteria also contain 
outer membrane-localized receptors specific to a particular siderophore (Figure 1.2) [17]. The 
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importance of siderophores to bacterial pathogenesis has been established in numerous studies 
demonstrating that mutant strains devoid of siderophore production are severely attenuated in 
many different models of infection [17-19]. Additionally, numerous strains of pathogenic 
bacteria, including Escherichia coli and Klebsiella. pneumoniae, synthesize more than one 
siderophore and mutant strains that are restricted to the synthesis of a single siderophore often 
demonstrate organ-specific virulence defects [19]. These findings demonstrate the temporal and 
spatial specificity between different siderophores and have prompted investigators to evaluate 
the potential of siderophores as vaccine candidates. Thus far, two reports demonstrate that 
immunization with siderophores mounts an effective host immune response that reduces 
bacterial burdens within the vaccinated host [20, 21]. Thus, host antibodies that bind the 
siderophore can be generated that obstruct siderophore-mediated import of host iron into the 
pathogen. 
 
Types of siderophores and biosynthesis 
Siderophores are classified into five different families based on the chemical signature of 
the iron-binding moiety. Catecholate, phenolate, hydroxamate, and α-hydroxycarboxylate 
represent four of the five classifications. The fifth classification represents mixed siderophores 
that contain more than one iron-binding moiety [22].  
Siderophore synthesis occurs via one of two mechanisms. The first mechanism is 
dependent on large multi-enzyme complexes called non-ribosomal peptide synthetases (NRPSs) 
that bind precursor molecules and catalyze the synthesis of the siderophore synthesis using 
energy generated from ATP hydrolysis. Specific genes within the siderophore operon create the 
prerequisite precursors molecule needed for the NRPS. Next, the precursor molecules are 
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assembled into the siderophore product with the aid of other enzymes present within the NRPS 
complex. NRPSs are composed of multiple large enzymes working in an assembly line to 
incorporate the needed amino acid into the growing polypeptide chain that will make up the 
siderophore. These NRPSs have three main domains; however, they can have more depending on 
the structure of the siderophore. First, the adenylation domain recognizes the incoming amino 
acid that will be incorporated. Next, the growing chain is covalently tethered to the peptidyl 
carrier protein (PCP) domain, sometimes referred to as the thiolation domain. Finally, the 
condensation domain incorporates the amino acid into the product. Condensation reactions can 
occur multiple times until the chain is cyclized by the thioesterase domain, also called the 
termination domain [16].  
Alternatively, siderophore biosynthesis can occur independently of the NRPS using 
NRPS-independent synthetases (NIS). The NRPS-independent pathways are not as well studied; 
however, recent reports have shown that NRPS-independent siderophores contain their own 
synthetases within the siderophore operon that catalyze various condensation reactions that form 
amide or ester bonds between the precursor molecules [23]. In both systems, the final product is 










Figure 1.2. Siderophore loci and structure. 
(A) The loci for enterobactin, salmochelin, yersiniabactin, and vibriobactin are depicted with 
biosynthetic, transport, and accessory genes annotated. (B) The corresponding siderophore 
structures are shown. 
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Upon siderophore binding of iron in the extra-cellular space, the molecule undergoes a 
conformational change, allowing the iron-siderophore complex to be recognized by specific 
bacterial cell surface receptors expressed within the outer membrane of Gram-negative bacteria. 
This interaction facilitates import. The outer membrane-localized receptors typically consist of a 
beta-barrel structure with a domain inside the barrel that creates a “plug” [24]. Studies have 
shown that reconfiguration of the “plug” domain allows for the passage of the siderophore-iron 
complex through the barrel [25]. The TonB complex, consisting of three proteins, TonB, ExbB, 
and ExbD, utilizes the proton motive force (PMF) to couple energy from the inner membrane to 
drive import of the substrate across the outer membrane [26]. Once the iron-siderophore complex 
is transported into the periplasm, transporters of the ATP-binding cassette (ABC) superfamily 
are responsible for passage of the complex across the inner membrane and into the cytoplasm. 
The energy required for this transport is generated via ATP hydrolysis. ABC transporters 
typically consist of three distinct functional units: a lipoprotein that binds the siderophore-iron 
substrate in the periplasm, a permease composed of two proteins located within the cytoplasmic 
membrane and that function as the channel through which the siderophore-iron complex 
traverses, and a cytoplasmic ATP hydrolysis enzyme (Figure 1.3). Typically, the genes encoding 
a siderophore ABC transporter are located in close proximity within the genome to the genes 
encoding the siderophore biosynthesis enzymes. However, some pathogens express orphan ABC 
transporters that promiscuously import siderophores produced by other bacteria [27]. The most 
well-known and best-characterized ABC transporter is found in E. coli and consists of FhuBCD 
proteins. 
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Once in the cytoplasm, iron must be liberated from the siderophore for it to be utilized in 
various enzymatic processes. Two unique mechanisms facilitate the release of iron from the 
siderophore. The first mechanism is mediated by an enzyme called ferrisiderophore reductases 
that catalyzes the reduction of Fe3+ to Fe2+. Because siderophores bind Fe2+ with a lower affinity 
than Fe3+, the Fe2+ is easily released. Alternatively, some bacteria release iron through enzymatic 
hydrolysis of the siderophore; however, this disrupts the integrity of the complex and is costly 
because the siderophore is unable to be recycled. Therefore, an advantage of the reductase-
mediated strategy of iron release is that the siderophore can be recycled to retrieve another Fe+3 
atom [22].    
 
Stealth siderophores that evade the immune response 
In the continuous evolutionary battle between host and pathogen, vertebrates are 
equipped to impede siderophore-mediated iron acquisition. The lipocalin family of proteins bind 
a diverse set of small molecules with a subset sequestering catecholate- and phenolate-type 
siderophores. For instance, lipocalin 2 (also referred to as 24p3, NGAL, or siderocalin) binds 
enterobactin, a siderophore commonly produced by the Enterobacteriaceae [28]. The importance 
of this siderophore countermeasure is demonstrated by the observation that lipocalin 2-deficient 
mice are more susceptible to Gram-negative infections [29]. In response to the selective pressure 
applied by the lipocalin family of proteins, pathogens adapted by evolving mechanisms to 
chemically modify their siderophores, blocking recognition by host siderophore-binding 
proteins. These so-called stealth siderophores contain slight chemical modifications to an 
existing siderophore, maintaining the high affinity for iron but abolish binding of the lipocalin 
family of host proteins. For example, E. coli synthesizes the siderophore enterobactin, which is 
 12 
bound by host immune protein, lipocalin 2. However, some strains of E. coli also encode the 
enzyme, iroB, which glycosylates enterobactin, resulting in a modified enterobactin called 
salmochelin (Figure 1.2). Lipocalin 2 fails to bind salmochelin, allowing the stealth siderophore 
to bypass host sequestration of enterobactin such that E. coli can achieve unperturbed acquisition 
of host iron [30]. Enterobactin is also found in many commensal strains of E. coli while stealth 
siderophores are much more common in pathogenic strains [31]. In addition to the synthesis of 
stealth siderophores, many pathogens are also equipped with the capacity to scavenge 
siderophores produced by other bacterial species [32]. Together these mechanisms enhance the 
iron acquisition strategies of invading pathogens ensuring that the requirement for iron is 
satisfied during infection.   
 
Iron acquisition via heme uptake 
Heme represents the most abundant iron-containing molecule in vertebrates. Not 
surprisingly, many pathogens, especially those that proliferate within the vasculature, target host 
heme to fulfill the iron requirement. Heme acquisition begins with the lysis of erythrocytes, 
liberating the enclosed hemoglobin. Each hemoglobin contains four heme molecules and each 
erythrocyte contains approximately 270 million hemoglobins [33]. Therefore, lysis of one 
erythrocyte results in a tremendous yield of iron for the pathogen. Hemolytic activity is a 
virulence trait associated with many Gram-negative pathogens [34]. 
Some pathogens are equipped with additional mechanisms that facilitate acquisition of 
heme from reservoirs less abundant than hemoglobin. One example is the heme-binding protein 
hemopexin that functions to alleviate heme-mediated damage to host tissues [4]. The high 
reactivity of heme requires that the molecule be complexed to proteins to prevent illicit damage 
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to other host molecules. Consequently, the amount of ‘free’ heme is kept low in order to protect 
tissues from heme-induced redox damage. Hemopexin functions in this capacity and is a viable 
source of heme-iron for Gram-negative pathogens, such as Serratia marcescens, but not all 
pathogens are capable of stealing heme from hemopexin. A common strategy is to procure the 
hemopexin heme using a siderophore-like mechanism that outcompetes hemopexin for heme. 
This is the case for S. marcescens, which will be discussed later in this chapter.  
Gram-negative heme acquisition systems 
Enterobacterales also target heme-containing hemoglobin as a source of iron. But first, 
the pathogen must lyse erythrocytes to liberate hemoglobin from these cells and initiate heme 
acquisition. To accomplish this, S. marcescens and E. coli rely on the hemolysins ShlA and 
HlyA, respectively [35, 36]. Gram-negative bacteria capture the heme liberated via hemolysis 
utilizing two distinct mechanisms: direct heme binding to outer membrane receptors or secretion 
of hemophores that scavenge the heme, subsequently passing the heme to their cognate receptor 
(Figure 1.3). Some Gram-negative bacteria possess both hemophore-mediated and receptor-
mediated systems, such as Serratia marcescens; however, it is more common for the pathogens 
to employ one or the other. Two heme receptors have been extensively characterized in 
uropathogenic E. coli, ChuA and Hma; however, more than 30 heme receptors have been 
described in Gram-negative species [37]. Outer membrane heme receptors are similar to the iron-
siderophore complex receptors described above both in terms of structure and the utilization of 
the PMF to drive import [38]. Heme receptors are β-barrels that encode specific residues within 
extracellular domains that bind heme. Two of these domains, FRAP and NPNL, contain 
conserved amino acid motifs in the extracellular loops of outer membrane receptors that are 
critical for heme import. These domains function to bind heme and transport it through the outer 
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membrane. The β-barrel heme receptors rely on the TonB protein complex to couple energy from 
the inner membrane to power heme import [39]. Gram-negative pathogens also utilize 
hemophores to scavenge heme. One of the best-described hemophores is HasA produced by S. 
marcescens which will be discussed later in this chapter [40].  
Periplasmic binding proteins (PBPs) are responsible for shuttling heme from the outer 
membrane through the periplasm to the inner membrane. PBPs that bind heme have been 
identified in Pseudomonas aeruginosa, Shigella dysenteriae [41], and Yersinia pestis. PBPs 
coordinate heme binding using a conserved tyrosine residue within a cleft connected via the N 
and C termini [42]. The heme-binding PBPs then pass the heme to dedicated ABC transporters. 
Analogous to siderophores, ABC transporters hydrolyze ATP to mediate heme delivery to the 
cytoplasm. While the outer membrane receptors for both siderophores and heme are incredibly 
substrate-specific, the ABC transporters do not seem to be. For example, P. aeruginosa encodes 
approximately 34 TonB-dependent outer membrane receptors, but only four ABC transporters 
function in iron import [43]. Therefore, it is likely that the same ABC transporters used for 
siderophore-iron import are also used to import heme.  
Gram-negative bacteria employ heme oxygenases to degrade heme. In addition to iron, 
biliverdin and carbon monoxide are products of heme degradation in these organisms. A new 
mechanism of heme degradation has recently been reported in the Gram-negative pathogen, 
enterohemorrhagic E. coli O157:H7. In aerobic environments canonical heme oxygenases 
catalyze the release of iron from heme, using oxygen as a cofactor. However, bacteria capable of 
growing in anaerobic environments, such as the gut, must have alternative mechanisms to 
liberate iron from heme without oxygen. E. coli O157:H7 encodes an operon for heme uptake 
that includes three additional uncharacterized genes, chuW, chuX, and chuY. Elegant biochemical 
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experiments demonstrated that ChuW uses the oxidizing potential of a carbon radical to free 
heme-bound-iron through a methyl transfer reaction leading to the rearrangement of the heme 
porphyrin ring. The complete mechanism of this reaction is currently not known; however, 
ChuW catabolizes the porphyrin ring of heme yielding free iron and a tetrapyrrole called 
anaerobilin (Fig. 2B) [44]. ChuY breaks down and reduces anaerobilin, a potentially toxic 
product of heme degradation. chuW and chuY are co-transcribed, suggesting a comprehensive 
mechanism of anaerobilin synthesis by ChuW after iron liberation from heme followed by 
anaerobilin reduction by ChuY [45]. Results from LaMattina et al. show that anaerobic bacteria 
have systems to extract iron from heme without using oxygen as a substrate. Heme oxygenase 
reduces the bound ferric iron to ferrous iron through a series of steps to break bonds within the 












Figure 1.3. Bacterial heme and siderophore uptake strategies. 
The host heme sources that are targeted by bacterial heme transporters and hemophores are 
described. Hemophores are synthesized by the bacterium and exported to scavenge for heme. 
Membrane transporters interact with hemophores or take up heme independently. Siderophores 
target iron bound to the host proteins described. Siderophores are produced intracellularly, 
exported, and then transported back into the bacterium after binding iron. 
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Coordinating the iron acquisition systems 
Heme and iron are exceedingly toxic at high levels. Therefore, bacteria that target both 
iron and heme reservoirs within the host must coordinate expression of the acquisition systems to 
maintain iron homeostasis without corresponding toxicity. It is likely that the host contains 
niches where the abundance of the various iron sources may dramatically change depending on 
the tissue being colonized. In keeping with this paradigm, siderophore-mediated iron acquisition 
may be better suited for colonization of distinct organs or tissues compared to heme-mediate 
acquisition systems or vice versa. Thus, bacteria must coordinate the expression of the 
acquisition systems to maximize fitness during infection of distinct niches. We are just beginning 
to understand the interplay between the iron acquisition systems but a recently described 
transcriptional regulator expressed in Staphylococcus aureus, a Gram-positive pathogen, has 
emerged that serves as a coordinator of iron acquisition systems.  
SbnI is a transcriptional regulator encoded within one of the S. aureus siderophore 
synthesis operons. S. aureus produces three siderophores, a nicotinamine-like broad spectrum 
metallophore called staphylopine and two a-hydroxycarboxylate siderophores: Staphyloferrin A 
and Staphyloferrin B. The sbn operon encodes the genes required for Staphyloferrin B synthesis. 
sbnI is the terminal gene of a nine gene operon. The function of SbnI remained elusive as the 
other genes, sbnA-H, emerged as enzymes encoding the siderophore synthesis or efflux proteins. 
Recent work demonstrated that SbnI enhanced the expression of sbnD-H in conditions of low 
iron. Notably, SbnI-dependent expression of sbnD-H is dependent on the presence of heme. SbnI 
is capable of binding heme and this reduces the affinity SbnI has for its DNA promoter sequence 
within the sbnD gene. In the presence of heme the expression of sbnD-H is decreased, reducing 
the production of Staphyloferrin B. Therefore, SbnI coordinates the production of Staphyloferrin 
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B in iron deplete environments devoid of heme. However, in iron depleted environments 
containing heme, Staphyloferrin B is not produced [47, 48]. This elegant coordination of heme 
and siderophore iron acquisition maximizes S. aureus iron acquisition and ensures that the 
bacterium maintains sufficient iron during pathogenesis.  
 
Introduction to Serratia marcescens  
Serratia marcescens (referred to as Sm throughout this dissertation) is a Gram-negative, 
facultative anaerobic bacillus within the Enterobacterales order that is frequently found in 
environmental settings. It infects plants and insects, and due to its low nutritional needs, is able 
to survive in soil and aquatic reservoirs such as drinking water [49]. For many years, S. 
marcescens was thought of as a nuisance as it is also commonly found in the grout of tiling as 
well as being a common bathroom contaminant, and generally was not considered pathogenic. 
However, only over the last four decades has S. marcescens been appreciated for the clinical 
threat it poses. S. marcescens infection prevalence is increasing in hospitals worldwide, and is 
now recognized as an important opportunistic pathogen associated with nosocomial infections 
and alarming rates of antibiotic resistance. In fact, a study in Poland revealed S. marcescens to be 
the fifth most commonly isolated bacterium from the Enterobacterales order nationwide from 
2003-2004 [50]. Another study in Japan implicated S. marcescens as the fifth most common 
cause of UTIs in 2008 [51]. Additionally, S. marcescens outbreaks in hospitals have been on the 
rise since the 1960s. By 1977, over 100 S. marcescens outbreaks were described [52], occurring 
in ICUs [53-60], surgery units [61-63], obstetric wards [64], and outpatient clinics [65] as well as 
more. Finally, in 2011, six patients were diagnosed with S. marcescens infections that were 
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traced back to a soap dispenser in an ICU in India [66]. These studies reflect the importance of S. 
marcescens as an emerging pathogen.  
S. marcescens causes many types of infections such as meningitis [67, 68], urinary tract 
infections [69-72], pneumonia [73, 74], bacteremia, and endocarditis [72, 75, 76]among others. It 
can also colonize indwelling catheters and medical devices. Mortality rates among these 
infections vary depending on the type of infection and the underlying condition of the patient. 
Because S. marcescens is an opportunist, immunocompromised patients including neonates are 
at high risk with mortality rates above 40% [77]. Treating S. marcescens infections is extremely 
difficult because of its antibiotic resistance profile. S. marcescens isolates can be resistant to a 
wide range of antibiotics including ampicillin, amoxicillin, cephalosporins, cephamycins, 
colistin, and several others [78-80]. Intrinsic resistance to colistin is especially concerning as this 
is typically a last-resort antibiotic. The presence of a chromosomal ampC confers resistance to β-
lactams, as well. It is also common for S. marcescens to have low level resistance to 
aminoglycosides, as many strains weakly express AAC(6’)-Ic, an aminoglycoside-modifying 
enzyme [81]. Some Serratia sp. strains are resistant to all clinically used aminoglycosides by 
expressing both 6’-N-acetyltransferase and the ANT(2”) enzyme [82]. Carbapenem resistance is 
uncommon in Serratia spp.; however, S. marcescens strains producing SME, a carbapenemase, 
as well as plasmids with carbapenemases have been found sporadically, which is highly 
concerning given that carbapenems are used to treat severe infections [83]. 
 
Bacteremia and Virulence Factors 
 S. marcescens is in the top 10 of pathogens that cause hospital acquired bloodstream 
infections [84]. Typically, the pathogen gains access to the bloodstream via the urinary tract, 
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respiratory system, or an open wound. If these infections are uncontrolled bacteria reach the 
bloodstream and the infection may quickly become systemic, resulting in septicemia with 
strikingly high mortality rate ranging from 23-52%. A study of European ICU-acquired 
infections in 2008 showed that Serratia caused 2.0% of all bloodstream infections, ranking it 
among the top frequently isolated organisms from bacteremia cases in the ICU [85]. 
Furthermore, a 2007 outbreak related to contaminated heparin syringes spread across nine states 
and resulted in 162 bacteremia cases with four deaths [86, 87].  
These Serratia outbreaks are becoming more common as S. marcescens finds its niche in 
the human host. The increase in outbreaks could be due to the previous dismissal of S. 
marcescens as a commensal or the genetic diversity seen between environmental isolates and 
clinical isolates particularly within virulence loci such as fimbriae, capsule, O-antigen, and 
toxins [88]. With the rise of Serratia infections, research interest examining virulence factors 
contributing to S. marcescens pathogenesis has also risen over the last ten years, giving the field 
some understanding of this otherwise uncharacterized emerging pathogen. 
A pore-forming toxin called ShlA is a common virulence factor associated with S. 
marcescens. Together with ShlB, ShlA destroys red blood cells as well as epithelial cells and 
fibroblasts [89]. ShlB is found in the outer membrane where it activates and secretes ShlA; 
however, these proteins are not released extracellularly and are contact-dependent. Therefore, the 
action of these proteins is dependent on the bacterium attaching to the cell to be lysed. Due to the 
cytotoxicity of this system and its ability to mediate inflammatory molecule release, it appears to 
be important to pathogenesis during UTI [90, 91]. Additionally, a regulatory pathway, called 
RssAB, regulating swarming and biofilm formation also regulates hemolysin production and 
seems to be important to virulence [92, 93]. Because S. marcescens is frequently found on 
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catheters and indwelling devices, its ability to quorum sense and produce biofilm is clinically 
important as this contributes to its resistance to antibiotics and evasion of the immune system 
[94-97]. S. marcescens also produces a capsule composed of acidic polysaccharides which aids 
in resisting opsonophagocytosis and complement-mediated killing [98]. Several other virulence 
factors of S. marcescens include secreted proteases, an extracellular phospholipase, as well as 
iron acquisition systems [99]. With S. marcescens emerging as a prevalent pathogen of concern, 
the field has recognized this bacterium's clinical importance, but the understanding of its 
virulence is lagging. While literature for S. marcescens various virulence factors exists, 
significantly more work is required to advance our understanding of S. marcescens pathogenesis, 
particularly with respect to its iron acquisition systems. 
 
Iron in Serratia marcescens 
The importance of iron in the context of Gram-negative pathogens has been extensively 
studied especially in E. coli. Studies have found iron uptake systems, including siderophores and 
heme uptake, in uropathogenic E. coli to have redundant but also hierarchical roles during 
infection [19]. Additionally, expression of particular siderophores in Klebsiella have been 
associated with hypervirulence [18, 100]. Because E. coli, K. pneumoniae, and S. marcescens are 
all members of the Enterobacterales order, it would not be surprising for them to produce similar 
iron acquisition systems; however, much less is known about how iron acquisition systems 
contribute to S. marcescens pathogenesis and if Serratia-specific systems exist.  
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Heme uptake in Serratia marcescens     
 Some studies of heme acquisition systems in S. marcescens have been completed. S. 
marcescens typically encodes two heme uptake systems, referred to as Hem and Has. The Hem 
system is composed of a TonB-dependent outer-membrane receptor and transports heme at 
concentrations above 10-6 M [101]. It functions by stripping iron directly from the heme 
molecule. The heme acquisition system or Has takes up heme at even lower concentrations (2.5 
x 10-8 M) by utilizing a secreted hemophore that scavenges for iron bound to heme. hasA encodes 
this hemophore, and in its proteinaceous form has a higher affinity for heme than hemopexin. 
This allows HasA to retrieve heme from host hemopexin. Has consists of the hemophore itself as 
well as an outer membrane receptor, HasR. HasR is structurally similar to the β-barrel heme 
receptors but HasR heme binding is significantly enhanced when it functions in concert with 
HasA [102]. HasA is secreted as a dimer and conserved tyrosine and histidine residues 
coordinate within a pocket to facilitate heme binding. These residues are critical for heme 
binding. HasR recognizes monomeric HasA; therefore, the function of the HasA dimer is not 
well understood. Once HasR binds HasA, both proteins undergo conformational changes leading 
to the exchange of heme from HasA to HasR [102]. The has system can function with a variety 
of heme sources [103, 104]; however, the same is not true for the Hem system, as it cannot strip 
heme from hemopexin [101]. Studies have shown that Hem and Has are not redundant, since 
each is individually favored at high and low heme concentrations, respectively [101]. However, 
expression of the Has system may be advantageous during infection, since extracellular heme 
concentrations are extremely low and the heme is typically bound to either hemopexin or 
hemoglobin. Although this has not been empirically tested, it suggests that the hemophore-
dependent has system may contribute more to virulence in this environment (Figure 1.4).     
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Serratia marcescens siderophores  
Most studies on Serratia species siderophores have been largely biochemical, identifying 
secreted siderophores using mass spectrometry or other methodologies, or clinical case studies, 
and not necessarily examining their contribution to pathogenesis. As a result, we know relatively 
little about Serratia marcescens siderophores. Previous work has shown Serratia liquefaciens 
and Serratia ficaria to encode the aerobactin biosynthesis locus, while S. marcescens typically 
encodes just the receptor [105, 106]. Enterobactin and ferric citrate have also reportedly been 
found in some S. marcescens strains [106]. However, a novel siderophore, first identified by 
Ehlert et al in 1994, called serratiochelin has been associated with S. marcescens [107]. This 
siderophore is predicted to be a result of the evolutionary mixing and matching of the 
enterobactin and vibriobactin synthesis pathways to produce it [108] (Figure 1.4).      
 
Serratiochelin 
Even though the initial identification of serratiochelin was in 1994, it has largely been 
overlooked in scientific literature since that time. However, with increasing S. marcescens 
prevalence in the clinic, studies on serratiochelin are becoming more common. A thorough 
characterization of serratiochelin which was purified from Serratia plymuthica sp. V4 was 
performed by Seyedsayamdost et al. This study identified three serratiochelin variances (A, B, 
and C), consistent in their molecular formula but differing in their structure. Although, 
serratiochelin C was not naturally occurring and was a hydrolytic product of A occurring during 
purification. Serratiochelin A coordinates iron using one of its catechols as one pair of ligands 
and the oxazoline N and one hydroxyl group as the second pair of ligands, complexing the iron 
ion with four ligands as a tetradentate [108].  
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The full serratiochelin gene cluster contains 21 open reading frames, involving both 
enterobactin and vibriobactin homologs. Within the enterobactin-related cluster, there are eight 
genes (schI-schP) for siderophore export and reuptake of the ferri-siderophore complex. The six 
remaining genes (schG, F0, C, E, B, A) are involved in synthesizing the serratiochelin molecule 
itself. SchG is highly similar to an enzyme called acetolactate synthase, which activates the first 
step in branched-chain amino acid biosynthesis. The remaining biosynthesis genes share 
homology to genes within the enterobactin biosynthesis operon in E. coli, with SchC, B, E, and 
A being involved in precursor molecule production and F0 acting as part of the NRPS 
machinery. Chorismate is the starting molecule to serratiochelin synthesis. Through a series of 
reactions involving SchC, B, and A, 2,3-dihydroxybenzoate (DHB) is produced and then handed 
off to SchE which adenylates DHB and passes it to SchB. Once tethered to SchB, the 
biosynthesis reaction proceeds in two directions, with the products of both reactions being 
combined to create serratiochelin A and B. The first direction involves SchH from the 
vibriobactin cluster. It attaches a nontethered propane-1,3-diamine to the SchB-tethered DHB. 
This propane-1,3-diamine is a unique backbone for a siderophore. The second direction involves 
incorporation of L-Thr into the SchB-tethered DHB. The peptide chain is handed off to enzymes 
within the vibriobactin-related gene cluster where the action of several NRPSs finish building the 
siderophore by incorporation of amino acids. This is an iterative process until the products of the 
two pathways are joined by amide bond formation [108].    
Serratiochelin is an interesting and unique siderophore because it has structural similarity 
to two separate siderophores, enterobactin and vibriobactin. This suggests the evolution of a new 
biosynthetic pathway through the combination and altering of these two clusters, resulting in a 
new siderophore. It is particularly advantageous for microbes to produce novel siderophores that 
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competing bacteria are unable to take up. Therefore, the evolutionary agility of siderophore 
clusters give bacteria a competitive advantage especially in polymicrobial environments.   
 
Chrysobactin 
In addition to serratiochelin, S. marcescens has been reported to also produce a lower 
affinity siderophore called chrysobactin. Chrysobactin was initially isolated in the plant pathogen 
Dickeya chrysanthemi and was essential for pathogen dissemination in the host plant [109]. 
Because of S. marcescens’ environmental niche and ability to infect plants, identification of 
chrysobactin in the S. marcescens genome is not entirely surprising; however, the role it plays in 
human infection is unclear. 
Chrysobactin is a catecholate siderophore and, in the case of Dickeya chrysanthemi, can 
have mono-, di-, tri-metric forms, as well as cyclized structures [109]. It is an NRPS-dependent 
siderophore that incorporates L-serine and D-lysine into the 2,3-dihydroxybenzoic acid 
backbone. CsbABCE produces 2,3-DHB which is passed to the NRPS protein, CbsF, where the 
amino acids are added to the growing chain. CbsF, contains eight NRPS domains to synthesize 
the final chrysobactin molecule [110]. Outside of plant pathogenesis, chrysobactin has not been 
studied in the context of mammalian disease. 
 
Siderophore transport in S. marcescens 
 Siderophore export is an ongoing area of study and is not fully understood in most gram-
negatives. For example, enterobactin is one of the most well characterized siderophores in terms 
of its production and reuptake [111]; however, its export is still under scrutiny. EntS, an ABC-
type transporter is involved in enterobactin export [112], but additional studies have suggested 
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resistance-nodule-division (RND) family efflux pumps to also play a role in enterobactin export 
[113]. Therefore, these studies indicate that siderophore export is complicated, potentially 
involving several proteins and enzymes. More is known with respect to enterobactin reuptake 
and transport back into the bacterium. Enterobactin has several dedicated cell surface receptors 
dependent on the TonB complex. It traverses the periplasm using periplasmic binding proteins 
and crosses the inner membrane with the ABC transporter consisting of permease and ATPase 
proteins, called FepBCDE [111] (Figure 1.4). Much less is understood with siderophore export 
and reuptake in S. marcescens, but is most likely similar to other gram-negatives. Within both 
the chrysobactin and serratiochelin loci, there are putative exporters; however, their role in 
export has not been empirically tested. A study identified the efflux pump, MacAB, to possibly 
be involved in siderophore export in S. marcescens strain SR41-8000, but did not contribute to 
export in strain SM6 [114]. Like enterobactin, this suggests S. marcescens siderophore export is 
also complicated. Additionally, while receptors and fepBCDE-like genes are found within the S. 
marcescens chromosome, transport of serratiochelin has not been extensively studied and the 
mechanism behind the transportation pathway has not been characterized. While it is 
hypothesized to function similarly to other gram-negative pathways, the results in Chapter III 







Figure 1.4. Predicted heme and siderophore systems in Serratia marcescens. 
S. marcescens has two previously described heme uptake systems, Hem and Has. The has system 
encodes a hemophore, HasA. Has brings in heme from hemopexin or hemoglobin while Hem 
targets only iron from hemoglobin. Chrysobactin and serratiochelin are two predicted 
siderophores of S. marcescens with corresponding outer membrane receptors. Heme and 
siderophore receptors are TonB-dependent and are internalized using a periplasmic binding 
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protein (PBP), which then interacts with an ABC transporter. For siderophore transport, this is 
most likely a Fep-like complex as described in E. coli. Once the heme or siderophore iron 























Siderophores and Pathogenesis 
There have been few studies examining how the siderophores found in S. marcescens 
actually contribute to pathogenesis and none that have looked at virulence in a mammalian host. 
In a Caenorhabditis elegans infection model, one study identified mutants with reduced 
virulence using a transposon library constructed in S. marcescens Db11. A mutation within a 
predicted siderophore biosynthesis gene conferred attenuated virulence within this model [91]. 
To date, the connection between S. marcescens siderophores and mammalian infection is 
unknown.  
 
Regulation of Iron Systems in S. marcescens      
 I speculate that the regulation of S. marcescens iron systems parallels those of other 
Gram-negative species. Fur boxes are present upstream of the known siderophore biosynthesis 
operons as well as the Hem and Has heme uptake operons, suggesting that these operons are 
repressed by Fur when iron levels are adequate [17]. In other microbes, siderophore expression is 
sometimes influenced by temperature and oxidative stress [115-117]; however, iron system 
expression under these conditions in S. marcescens has not been examined. Since S. marcescens 
is found in diverse ecological niches, additional environmental cues may also regulate its iron 
systems.      
 
Summary and Chapter Outline 
This chapter summarized the current knowledge of iron acquisition systems in the context 
of Serratia marcescens. Because S. marcescens has a history of infecting plants, insects, and 
surviving in a variety of environmental settings, some features of its pathogenesis may 
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potentially be unique when compared to other gram-negative microbes, and should not be 
assumed to follow typically understood mechanisms of pathogenesis specifically related to iron 
acquisition. The following chapters aim to elucidate some of these mechanisms. Chapter II 
identifies the iron-regulated transcriptome of Serratia marcescens isolate UMH9 using RNA-
sequencing to provide a complete outline of all genes involved in iron uptake. Interesting 
systems that were identified by RNA-seq and hypothesized to contribute to UMH9 pathogenesis 
guided the questions addressed in subsequent chapters. Chapters III and IV home in on putative 
siderophore systems that were identified in Chapter II. Chapter III describes interesting findings 
suggesting how Sm NRPS machinery may be involved in siderophore transport. Chapter IV 
defines the contribution of Sm siderophores to mammalian pathogenesis. Finally, Chapter V 
outlines preliminary conclusions on Sm heme acquisition systems and their potential 
involvement in heme toxicity. Together, the findings presented herein provide novel insights into 




 Identification of the Iron-Regulated Transcriptome of Serratia marcescens 
Clinical Isolate UMH9
 
Notes. The results presented in this chapter were adapted from the following article:  
 
Weakland DR, Smith SN, Bell B, Tripathi A, Mobley HLT. The Serratia marcescens 
Siderophore Serratiochelin Is Necessary for Full Virulence during Bloodstream Infection. Infect 
Immun. 2020; 88(8): e00117-20. Published 2020 Jul 21. doi:10.1128/IAI.00117-20 
 
Abstract. 
Serratia marcescens is an emerging infectious pathogen; however relatively little is known 
regarding its pathogenesis and virulence factors, particularly with respect to iron acquisition 
systems. Therefore, addressing this knowledge gap was the overarching goal of my dissertation. 
By taking a global transcriptomic approach to identify all genes regulated by iron concentration, 
the results of this chapter provide the foundational work to describing how iron acquisition 
contributes to virulence in Sm. RNA-sequencing in iron-depleted conditions on a clinical isolate 
of Sm called UMH9, revealed two previously identified heme uptake systems called hem and has 
as well as two putative siderophore loci. In addition to heme and siderophore uptake, ferrous iron 
transporters and ferric citrate transporters were upregulated under iron-limited conditions. 
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Finally, seven orphan transporters that were located outside of dedicated iron transport loci were 
identified by RNA-seq, suggesting UMH9’s ability to import siderophores from other microbes 
or additional transporters for its own siderophores. The results of this RNA-seq experiment 
provided a comprehensive inventory of the arsenal of iron acquisition genes in the UMH9 
genome. These findings informed the iron acquisition systems that were studied in depth in the 






Bacterial access to iron is crucial because of its many roles in cellular processes such as 
serving as an enzyme cofactor and its involvement in electron transfer. As such, bacteria encode 
several types of iron uptake systems, many of which have been described across bacterial 
species. These systems include hundreds of different siderophores as well as heme uptake 
systems, but also consist of independent siderophore/iron receptors [22, 118]. Siderophores and 
heme uptake are the main systems involved in bacterial iron scavenging but machinery that takes 
up ferrous iron or citrate, a very low affinity iron chelator, are also typical across bacterial 
genomes [119]. This is the case for uropathogenic E. coli which encodes four potential 
siderophores as well as two heme uptake systems. Additionally, it possesses “orphan” receptors 
that are not located within siderophore biosynthetic loci that still take up ferri-siderophores, and 
citrate import genes [19]. 
The iron acquisition machinery of many human bacterial pathogens has been described; 
however, research is severely lacking on iron uptake ability and how it relates to pathogenesis for 
emerging pathogens such as Serratia marcescens. Sm, initially thought of as an exclusively 
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environmental pathogen and nonvirulent in humans, is being seen with increasing prevalence in 
the clinic causing fatal bloodstream infections [99]. Some of its virulence factors have been 
described including the production of a hemolysin, ShlA, and a rigid capsule [90, 98]. 
Nonetheless, how iron acquisition contributes to the pathogenesis of a bacterium that has evolved 
into a concerning clinical pathogen is yet to be explored.  
Two heme uptake systems have been identified previously in nonclinical isolates of Sm 
[101, 120]; however, the full repertoire of iron uptake genes has not been described in a clinical 
isolate of Sm, let alone Sm itself. Therefore, in this Chapter, I identified the complete iron-
regulated transcriptome of Sm clinical isolate UMH9 using RNA-seq to acquire a comprehensive 
understanding of all dedicated iron uptake systems, as well as orphan genes related to iron. The 
results of this study enabled me to identify two siderophore loci within the Sm genome that had 
not been reported on in clinical isolates of Sm. This global approach provided a big picture 
snapshot of all the iron uptake machinery encoded by UMH9, providing an appreciation for iron 
acquisition in a clinical isolate of Sm.  
The results presented here guided the direction of this total project with the overarching 
goal of achieving a complete characterization of iron acquisition in Sm as an opportunistic 
mammalian pathogen. In the following Chapters, I homed in on the identified major iron uptake 








Identification of the S. marcescens transcriptome during iron limitation  
To identify iron-dependent genome-wide changes in transcription, differential gene 
expression of S. marcescens strain UMH9 under iron-rich and iron-limited conditions was 
quantified using RNA-seq. Three concentrations (125µM, 200µM, 250µM) of dipyridyl, an iron 
chelator, were added to LB medium to empirically find sub-inhibitory levels of iron-limitation 
(Figure 2.1). Transcripts isolated at mid-log phase (3 hours) from UMH9 cultured in LB and LB 
supplemented with 200µM dipyridyl were sequenced and analyzed to identify differentially 
regulated genes. 114 genes were significantly up-regulated (Appendix A, Table A.1) and 46 
genes were significantly down-regulated (Appendix A, Table A.2) during iron-limitation.  
Upregulated genes consisted of those involved in iron-transport and siderophore 
biosynthesis, confirming that iron-limitation was achieved. Genes downregulated in iron poor 
conditions were involved in iron storage as well as metabolic processes such as glycolysis, 
nitrate anaerobic respiration, and succinate metabolism consistent with the reduced cellular 
growth observed under these conditions, suggesting that cells potentially do not achieve a 





Figure 2.1. Serratia marcescens UMH9 growth is abrogated by increasing concentrations of 
dipyridyl. 
Dipyridyl was added 0, 125, 200, and 250µM to S. marcescens UMH9 cultured in LB medium. 
Bacterial growth was measured by monitoring OD600 every hour as cultures were incubated with 
aeration at 37˚C. A concentration of 200µM dipyridyl was used to achieve iron-limiting 



























Up-regulated genes related to iron uptake were grouped into systems. Heme uptake 
systems, hem and has, were identified. The hem operon is composed of seven genes including an 
outer membrane heme receptor as well as components for ABC transport through the perisplasm. 
The has system also has seven genes that include genes encoding the hasA hemophore and the 
corresponding hasR receptor. Genes involved in ferrous iron uptake were upregulated and 
identified as the sit and efe systems. The sit system is composed of four genes, sitABCD, that 
constitute components for ABC transport through the inner membrane. Three genes were 
identified in the efe ferrous iron uptake system, efeBOU, consisting of a peroxidase, periplasmic 
binding protein, and a permease. A ferric-citrate uptake system, fecARI, was upregulated that 
encoded a receptor and two regulatory elements. The results also identified two putative 
siderophore operons. The first locus was composed of five genes (BVG96_RS08795-08815), 
encoding a receptor, exporter, and biosynthetic elements. The second locus had fifteen 
upregulated genes: eight involved in biosynthesis, three involved in transport, one involved in 
degradation, and three hypothetical proteins. Seven additional orphan TonB-dependent 
transporters were up-regulated as well, including a predicted aerobactin receptor, suggesting that 
UMH9 can import siderophores through multiple transporters or bring in xenosiderophores. 








Table 2.1. Up-regulated iron acquisition systems in Serratia marcescens UMH9 during 
iron-limited RNA-seq. 
Function Locus Tag 
BVG96_RS… 
Gene Description Log2FCa 
Heme uptake 01515 hasI RNA polymerase sigma 
factor 
3.38 
01520 hasS Antisigma factor 3.09 
01525 hasR TonB-dependent receptor 5.25 
01530 hasA Hemophore 6.64 
01535 hasD Type I secretion system 
permease/ATPase 
4.04 
01540 hasE Periplasmic adaptor subunit 3.90 
01545 tonB/hasB Energy transducer 3.03 
07350 hemV Heme ABC transporter 
ATP-binding protein 
5.70 
07355 hemU Hemin ABC transporter 
permease 
6.54 
07360 hemT Periplasmic hemin-binding 
protein 
6.25 
07365 hemS Hemin-degrading factor 6.89 
07370 hemR TonB-dependent receptor 7.77 
07375 hemP Hemin uptake protein 7.48 
07380 
 
Glutathione peroxidase 3.97 
Ferrous iron uptake 07170 sitD Iron ABC transporter, inner 
membrane permease 
2.18 
07175 sitC Iron ABC transporter, inner 
membrane permease 
Not represented 
07180 sitB Iron ABC transporter, 
ATP-binding protein 
2.87 
07185 sitA Iron ABC transporter, 
periplasmic-binding protein 
3.36 
11025 efeB Iron transport peroxidase 2.75 
11030 efeO Iron transport periplasmic 
protein 
2.79 
11035 efeU Iron transport permease 2.77 
Ferric citrate transport 07970 fecA TonB dependent receptor 5.45 
07975 fecR Operon regulator 6.02 






















TonB-dependent receptor 6.28 
21965 
 
Condensation protein 5.12 
21970 
 
Adenylation protein 5.96 
21975 
 




TonB-dependent receptor 7.62 
21985 
 
Condensation protein 6.65 
21990 
 
Hypothetical protein 6.47 
21995 
 














Siderophore exporter 3.61 
22020 
 


































































This Chapter took a global approach using RNA-seq to identify the iron-regulated 
transcriptome of a clinical isolate of Serratia marcescens. The results revealed all genes involved 
in iron acquisition and provided a starting point for follow-on studies examining the identified 
systems.  
Results from iron-depleted RNA-sequencing identified iron uptake systems including 
siderophore biosynthetic loci, heme uptake systems, ferrous iron uptake, and citrate utilization 
systems. An additional seven Ton-B dependent receptors were also regulated by iron acquisition 
that were located outside of these loci. While these systems have been reported in other Gram-
negatives, this is the first study to comprehensively identify all genes and systems involved in 
Serratia marcescens iron acquisition, a bacterium that has a unique history as an environmental 
pathogen evolving to become pathogenic in humans.  
Because Serratia has a wide breadth of hosts, both environmental and mammalian, it is 
interesting to hypothesize where the identified iron acquisition systems may be most 
advantageous. For example, ferrous iron is more abundant in soils than in the human host [121]; 
therefore, the sit and efe systems may play a larger role in the environment than in mammalian 
infection. Iron acquisition via citrate uptake may prove to be advantageous in plant or insect 
pathogenesis where a lower affinity iron chelator is sufficient [122].  
Not only does UMH9 encode dedicated systems for siderophore, heme, ferrous iron, and 
citrate uptake, but the RNA-seq also identified seven “ophan” receptors that contribute to iron 
acquisition. It is unknown what role these receptors play in iron uptake; however, it is 
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hypothesized that they are additional receptors for siderophore import or piracy of siderophores 
produced by surrounding microbes.  
Together, these results provide a high-level perspective on all of the iron acquisition 
systems that well-equip Sm for iron uptake in many environments. Although, we do not know 
which ones contribute most significantly to human pathogenesis. Based on the RNA-seq results 
and the role siderophores and heme uptake play in mammalian infection caused by other Gram-
negatives, I crafted the studies presented in the proceeding chapters to elucidate how these 
systems contribute to the virulence of Sm.  
The results from this RNA-seq experiment were utilized to achieve the ambitious goal of 
this dissertation project, which was to fully characterize the major iron acquisition systems in a 
clinical isolate of S. marcescens.  
  
Methods and Materials 
 
Bacterial Culture and Development of Iron-Limited Conditions 
S. marcescens strain UMH9 was routinely cultured in LB medium at 37˚C. To achieve 
iron-depletion, overnight cultures of UMH9 in LB medium were collected by centrifugation the 
following day. Cultures were washed three times with LB medium containing 200 µM dipyridyl, 
an iron chelator. Bacteria were then sub-cultured into LB medium containing either 0 µM, 100 
µM, 200 µM, or 250 µM dipyridyl to determine an appropriate dipyridyl concentration before 
proceeding with RNA-seq. 
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RNA Purification and Sequencing  
S. marcescens strain UMH9 was cultured overnight at 37˚C in LB medium. The 
following day, bacteria were collected by centrifugation and washed three times with LB 
medium containing 200 µM dipyridyl. Washed bacteria were diluted 1:100 into either LB or LB 
+ 200 µM dipyridyl, and incubated at 30˚C with shaking until an optical density at 600nm 
(OD600) between 0.4 and 0.5 was reached. RNA was stabilized using RNAprotect (Qiagen). 
Bacteria were lysed by incubation for 10 minutes at room temperature with 15mg/ml lysozyme 
(Sigma-Aldrich) and 20mg/ml Proteinase K (Qiagen). The RNAeasy mini kit (Qiagen) was used 
to purify RNA according to the directions of the manufacturer. Turbo DNase (Thermo Fisher) 
was used to deplete genomic DNA contamination. RNA was further purified using the RNEasy 
mini kit (Qiagen). rRNA removal, library preparation, and sequencing were performed by the 
University of Michigan Sequencing Core using the ScriptSeq Complete Kit (bacteria) library kit 
(Illumina). cDNA libraries were sequenced using Illumina HiSeq 2500 (single-end, 50bp read 






Elucidating the Role of cbsF and schF0, Components of the NRPS Machinery, 
in Iron Transport 
 
Notes. The introduction of this chapter was adapted from the following article:  
 
Weakland DR, Smith SN, Bell B, Tripathi A, Mobley HLT. The Serratia marcescens 
Siderophore Serratiochelin Is Necessary for Full Virulence during Bloodstream Infection. Infect 
Immun. 2020; 88(8): e00117-20. Published 2020 Jul 21. doi:10.1128/IAI.00117-20 
 
Abstract.  
S. marcescens possesses broad environmental niches, and was initially dismissed as being 
a human pathogen. However, over the last several decades, it has caused severe infections with 
increasing frequency. Because S. marcescens has only recently been recognized as a threat to 
public health, little is known about factors contributing to S. marcescens virulence specifically 
regarding iron acquisition. The initial objective was to define how two siderophore loci, cbs and 
sch, found by RNA-sequencing analysis contribute to the pathogenesis of UMH9, a S. marcecens 
bloodstream isolate. Deletions were made mutating the non-ribosomal peptide synthetase 
(NRPS) machinery in each siderophore operon and then a double mutant deleting both together. 
Culturing in iron-poor conditions revealed that the double NRPS mutant had defective growth; 
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however, it still produced siderophore demonstrated by chrome azurol S (CAS) assay and mass 
spectrometry. The single NRPS mutants behaved similarly to wild type. These results suggest 
that the two NRPS genes could have redundant roles in siderophore transport, challenging the 




Historically, Serratia marcescens has been considered an environmental pathogen due to 
its ability to infect insects and survive in soil and aquatic reservoirs. However, over the last 
several decades, S. marcescens has emerged as a major opportunistic pathogen in humans 
causing deadly infections that include bacteremia and endocarditis [99]. Antibiotic-resistant 
isolates of this Gram-negative pathogen continue to arise [99] and emergent strains have been 
found to carry multiple virulence factors including a hemolysin, various proteases and nucleases, 
and a polysaccharide capsule[98, 123]. Despite these observations, it is clear that significant 
research is still required to advance our understanding of the pathogenesis of S. marcescens.  
Iron is essential to many cellular processes in bacteria, and therefore critical to 
pathogenesis [124]. Humans harbor approximately three to four grams of total iron within their 
bloodstream and tissues [125]; however, most of this iron is not readily available, as it is 
sequestered by host proteins including transferrin, ferritin, ferroportin, lactoferrin, myoglobin, 
and hemoglobin [126-128]. As such, free iron concentrations in serum are less than 10-24 M at 
physiological pH, requiring microbes to have developed specific strategies to access iron 
sequestered within host proteins and enable survival [129]. For example, heme acquisition 
systems use dedicated cell surface receptors in concert with the TonB complex to bind and 
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internalize host heme, releasing the iron molecule into the bacterial cytoplasm [37]. In addition, 
siderophores, small organic molecules with high affinities for iron (Kd > 10-30 M) [14], are 
synthesized by bacteria and exported to the extracellular space to scavenge iron from host 
proteins, including transferrin, lactoferrin, and ferritin. Outer membrane TonB-dependent 
receptors then facilitate the import of iron-loaded siderophores into the bacterial cytoplasm 
[127]. 
Iron acquisition has been studied extensively in the context of other Gram-negative 
pathogens, especially Escherichia coli [19]. For example, uropathogenic E. coli mutants lacking 
receptors for specific siderophores or heme import show decreased fitness in both the bladder 
and kidney in a mouse model of ascending urinary tract infection, establishing the importance of 
iron uptake during infections of the bladder and kidneys [18]. Additionally, hypervirulent strains 
of Klebsiella pneumoniae encode up to four siderophore systems [100]. These systems have been 
shown to induce host inflammatory cytokines and facilitate bacterial dissemination during 
pneumonia [101].  
Despite the importance of iron acquisition to the pathogenesis of other Gram-negative 
bacteria, comparatively little is known about the contribution of S. marcescens iron uptake 
systems to its pathogenesis in mammalian hosts. Nevertheless, there has been some work 
defining the molecular mechanisms of S. marcescens iron acquisition with particular focus on 
heme uptake, characterizing two systems, Hem and Has [130]; however, the only studies 
defining S. marcescens siderophores have been performed in non-mammalian systems. A 
transposon library constructed in S. marcescens Db11, initially described as a Drosophila 
melanogaster pathogen, was used to identify a mutation within a predicted siderophore 
biosynthetic gene that displayed reduced virulence in a Caenorhabditis elegans model of 
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infection [105]. Previous studies have shown several potential siderophores produced by Serratia 
species. For example, Serratia liquefaciens and Serratia ficaria produce the siderophore 
aerobactin, whereas S. marcescens does not. Many isolates, however, typically encode an 
aerobactin receptor [106, 108]. S. marcescens W225 synthesizes another siderophore, 
enterobactin, and can utilize ferric citrate as an iron source as well [108]. 
A siderophore, designated serratiochelin, is also commonly produced by the S. 
marcescens and Serratia plymuthica species. Biochemical studies have been undertaken to 
analyze serratiochelin synthesis.  The results allowed the authors to hypothesize that 
serratiochelin is a molecular hybrid of enterobactin and vibriobactin, based on gene similarity 
and mutagenesis experiments [107]. Other studies have shown that S. marcescens also produces 
a low-affinity siderophore, chrysobactin, first identified in Dickeya chrysanthemi [120]. Genes 
associated with the synthesis of either serratiochelin or chrysobactin have been found in 
sequenced genomes of other S. marcescens strains. For example, a clinical isolate of S. 
marcescens, SM6, is predicted to produce serratiochelin and chrysobactin based on genetic 
identity to the schF (nonribosomal peptide synthetase [NRPS] in S. plymuthica V4) and cbsF 
(NRPS in D. dadantii 3937) genes, respectively [131]. 
Many siderophores are synthesized through non-ribosomal peptide synthetase (NRPS) 
dependent pathways. Starting with precursor molecules, such as dihydroxybenzoate, 
siderophores are built by a series of enzymatic reactions on multidomain protein assembly lines 
called NRPSs that elongate the intermediate siderophore molecule. NRPSs typically consist of an 
initiation module, elongation module, and termination module, which, depending on the 
organism and complexity of the siderophore, can be encoded by many separate genes within the 
biosynthetic operon or within just a few. These three modules combined synthesize the final 
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siderophores by incorporating amino acids into the peptide product. Variations in the functional 
domains of the NRPS result in the production of many bacterial siderophores [16, 132].  
In this chapter, two siderophore loci were identified in a bloodstream isolate of Serratia 
marcescens UMH9 and predicted to synthesize chrysobactin (cbs) and serratiochelin (sch) based 
on previous literature. Deletions in predicted biosynthesis genes involved in the NRPS 
machinery from each operon (DcbsF and DschF0) individually had no effect on growth in iron-
poor medium or iron chelation. However, when NRPS components were deleted together in a 
double mutant (DcbsF/schF0), the double mutant had defective growth in iron-limited 
conditions. Despite this inhibited growth, siderophore production was notably increased 
compared to the WT and single mutants. Mass spectrometry identified serratiochelin to be 
present in all mutant supernatants, ruling out the production of an ineffectual siderophore caused 
by the double mutation. These results suggest a yet to be described novel role in siderophore 




cbsF and schF0 are non-ribosomal peptide synthetases involved in siderophore 
biosynthesis. 
From the RNAseq results in Chapter II, I identified two potential siderophore operons in 
UMH9. Based on their similarity to published chrysobactin and serratiochelin loci, I labeled 
them cbs and sch, respectively. To examine how each siderophore contributed to bacterial 
pathogenesis, I began by investigating cbsF and schF0.  cbsF and schF0 encode non-ribosomal 
peptide synthetases (NRPS) theoretically involved in the biosynthesis of chrysobactin and 
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serratiochelin, respectively. Further details on the composition of these loci will be covered in 
Chapter IV.  
Serratiochelin and chrysobactin both depend on NRPSs for production. Within the 28 kb 
locus responsible for serratiochelin biosynthesis, three to four genes, schF0, schF1, schF2, and 
schF3, presumably constitute the full NRPS machinery based on gene similarity to other known 
NRPSs. schF0 contains modules characteristic of an NRPS such as condensation, adenylation, 
thiolation, and thioesterase domains likely involved in elongation and termination processes. 
Several other genes likely involved in the NRPS machinery are also found in this locus (Figure 
3.1A). The chrysobactin locus is much smaller with only five genes, including an exporter, a 
receptor, a chaperone, and two biosynthesis genes. One large gene, cbsF, encodes all NRPS 
modules, including condensation, adenylation, thiolation, epimerization, and a thioesterase. It 
also contains repeated condensation, adenylation, and thiolation domains that incorporate 
additional amino acids into the growing siderophore within the same protein, negating the need 
for additional NRPS genes. This siderophore locus structure is often seen within fungal 
organisms; however, there are no reports detailing if chrysobactin has fungal origins (Figure 
3.1B) [133, 134]. 
I confirmed that the cbs and sch operons, including cbsF and schF0, were regulated by 
iron concentration using qRT-PCR from mid-log phase cultures in iron rich and iron-limited 





Figure 3.1. Domain structure of cbsF and schF0 reveal important moieties for siderophore 
synthesis and are up-regulated under iron-limitation. 
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The structure of the cbs (A) and sch (B) loci are depicted. Genes are annotated based on 
similarity to genes found in the chrysobactin and serratiochelin loci of Dickeya dadantii and 
Serratia plymuthica, respectively. More information on the Dickeya dadantii chrysobactin locus 
and the Serratia plymuthica serratiochelin locus can be found in Chapter IV (Figure 4.1). cbsF 
(A) and schF0 (B) contain domains pertinent to siderophore production. C = condensation, A = 
adenylation, T = thiolation, E = epimerization, Te = thioesterase. (C) cDNA from UMH9 WT 
cultured with and without dipyridyl were used to confirm the expression of cbsF and schF0 

















The DcbsF/schF0 mutant had defective growth in iron-limited conditions. 
I deleted cbsF (DcbsF) and schF0 (DschF0) individually and in combination 
(DcbsF/schF0) in the UMH9 wild type strain to abolish siderophore synthesis. Because NRPSs 
are typically essential for siderophore biosynthesis, I measured the ability of each mutant to grow 
in several conditions with varying iron concentrations. I expected the single mutants to perform 
similarly to WT as they still produced an intact siderophore, while the double mutant would have 
inhibited growth in iron-poor conditions since siderophore biosynthesis is presumably abolished.  
First, I measured growth in several M9 minimal medium conditions where iron was 
removed or added back in at 36 µM FeSo4. As expected, in growth medium where iron was 
replete, all strains grew similarly (Figure 3.2C, D). However, when iron was limited, the double 
mutant, DcbsF/schF0, grew worse than the other strains. The DcbsF/schF0 mutant was severely 
growth restricted under these conditions, and this growth defect was exclusive to iron-limitation 
as it grew similarly to the other strains when there was sufficient iron in the medium (Figure 
3.2A, B). This prompted me to examine at what concentration of iron the double mutant is able 
to overcome this growth defect. To test this, I titrated FeSO4 into iron-depleted M9 minimal 
medium at 0 µM, 1 µM, 10 µM, 20 µM, and 30 µM, and measured growth. The WT grew 
similarly at all tested iron concentrations with a slightly lowered saturation point at 0 µM FeSO4 
(Figure 3.3A). The double mutant had defective growth at 0 µM and 1 µM FeSO4, but grew 
comparably to WT at all other tested concentrations (Figure 3.3B). These results suggest that 
only a small amount of iron is needed for normal growth, and the double mutant is growth 
restricted at low iron concentrations where the WT is able to grow adequately.  
Finally, I examined growth in LB medium supplemented with dipyridyl (an iron chelator) 
to see how the double mutant fared when it had to compete for iron from a chelator already 
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present in the medium. Dipyridyl was titrated into LB medium at 0 µM, 125 µM, and 220 µM. 
WT and DcbsF/schF0 grew similarly in LB medium alone. While both the WT and double 
mutant had decreased growth with increasing concentration of dipyridyl, the DcbsF/schF0 
mutant showed notable defective growth at both of the tested dipyridyl concentrations. At 125 
µM dipryidyl, the WT saw similar growth to 0 µM, but the double mutant did show impaired 
growth (Figure 3.4A). Then, DcbsF/schF0 was growth restricted compared to the WT at 220 µM 
dipyridyl. The IC50 for dipyridyl was determined to be 152 µM for the double mutant, compared 

















Figure 3.2. The DcbsF/schF0 mutant displays defective growth in iron-poor media. 
The indicated strains were grown in either chelex treated (iron removed) (A, C) or normal M9 
minimal medium (B, D). 36µM FeSO4 was added to the cultures where indicated (C, D). 
Cultures were incubated with aeration at 37˚C and OD600 readings were taken every 15 minutes 
to measure bacterial growth. Results are representative of three biological replicates. 
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Figure 3.3. DcbsF/schF0 struggles to overcome its growth defect at low iron concentrations. 
The WT (A) and DcbsF/schF0 (B) strains were grown in chelex treated M9 minimal medium 
with 0 µM, 1 µM, 10 µM, 20 µM, or 30 µM FeSO4 supplemented into the culture. Cultures were 
incubated at 37 ˚C with OD600 readings were taken every hour for 9 hours. Results are 
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Figure 3.4. DcbsF/schF0 is inhibited by lower dipyridyl concentrations compared to WT. 
(A) The wild type and DcbsF/schF0 strains were grown in LB with 0µM, 125µM, or 220µM 
dipyridyl and growth was measured every hour for 9 hours. (B) The half maximal inhibitory 














































concentration (IC50) of dipyridyl was calculated for the WT and DcbsF/schF0 strains based on 






















Loss of both cbsF and schF0 together resulted in increased iron chelation. 
As expected, the double mutant severely struggled to grow in iron-limited conditions 
most likely due to insufficient iron uptake from the loss of siderophore function. In a chrome 
azurol S (CAS) assay measuring siderophore production, I hypothesized individual NRPS 
mutants would have minimal to no reduction in iron chelation since the other siderophore was 
still intact, while the double mutant would have significant reduction in siderophore production. 
To test the amount of siderophore production by each strain, I measured iron chelation using 
CAS agar. Strains were grown overnight in iron-depleted M9 minimal medium. These cultures 
were inoculated onto CAS agar the following day. After 48 hours of incubation at 37 °C, the 
WT, DcbsF, DschF0 mutants showed comparable iron chelation as they all had yellow circles of 
similar diameter surrounding the point of inoculation. Surprisingly, the double mutant, 
DcbsF/schF0, demonstrated notably more iron chelation than any other strain even though it had 
defective growth in iron-limited conditions. This suggests that a siderophore is still being 
produced but the bound iron is not able to be used when both cbsF and schF0 are deleted. 
Interestingly, the single mutants had phenotypes similar to the WT suggesting a redundant 







Figure 3.5. The DcbsF/schF0 mutant showed increased siderophore production. 
Iron chelation was measured using CAS agar plates. UMH9 WT and the mutant strains were 
cultured overnight in M9 minimal medium and spotted onto CAS agar the following day. A 
larger yellow circle surrounding the point of inoculation correlates to increased siderophore 
production. Images of the CAS plate for each strain after two days of incubation are shown (A). 



































Serratiochelin was detected in DcbsF/schF0 supernatants by mass spectrometry. 
Interestingly, DcbsF/schF0 had increased siderophore production observed on CAS agar 
despite the defective growth seen in iron-limited conditions. This suggests an alteration to the 
produced chelator caused by the double mutation that is affecting cellular use of the siderophore. 
Thus, I sought to identify siderophore precursor molecules of chrysobactin and serratiochelin 
that could be contributing to the increased chelation, but are potentially less able to provide 
sufficient iron to the bacterial cell. 
Mass spectrometry (MS) was performed on bacterial supernatants after WT, DcbsF, 
DschF0, and DcbsF/schF0 were cultured overnight in iron-depleted M9 minimal medium as well 
as in minimal medium supplemented with 36 µM FeSO4. Based on previous literature and the 
similarity of the putative sch locus to serratiochelin-producing operons, we used fragmentation 
patterns matching that of serratiochelin as a reference. MS/MS spectra obtained from bacterial 
extracts of the wild type and mutants were first analyzed using a global natural product search 
(GNPS)-based DEREPLICATOR+ algorithm for probing the presence of serratiochelin [135, 
136]. The algorithm compared our data set to all spectra in the GNPS database enabling high 
throughput identification of known natural products present in the bacterial extract. 
To analyze our samples using DEREPLICATOR+, we opted for a stringent score 
threshold of 0% false discovery rate (FDR) and removed the metabolites present in blank 
samples that consisted of M9 growth medium only. The analysis clearly showed the presence of 
an [M+H]+ ion at 430.1723 m/z and an [M+Na]+ ion at 452.1470 m/z (Appendix A, Figure A.1) 
with the molecular formula of C21H23N3O7, identifying the presence of serratiochelin A in all 
supernatants, including DcbsF/schF0, when iron was depleted. Serratiochelin was not found in 
culture supernatants supplemented with iron as expected (Figure 3.6). Taking these results with 
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the iron-depleted growth phenotypes, I hypothesize that the single NRPS mutants play a 














Figure 3.6. Serratiochelin is detected in all bacterial mutants by mass spectrometry. 
WT and the DcbsF, DschF0, and DcbsF/schF0 were cultured overnight in M9 minimal medium 
with or without iron. Mass spectrometry was performed on bacterial supernatants and identified 

















































Iron: + — + — + — + — 
ND ND ND ND
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The DcbsF/schF0 mutant is less fit and attenuated in the murine bacteremia model 
compared to WT.  
Next, I hypothesized that the inability to use serratiochelin in the double mutant may 
translate into a colonization or competitive disadvantage in the mouse bacteremia model [137], 
and since UMH9 was isolated from a bacteremic patient; I wanted to determine if its cbsF and 
schF0 contributed to its pathogenesis in vivo. I examined fitness of DcbsF/schF0 compared to 
WT by injecting an inoculum containing a 1:1 mixture of the double mutant and WT culture into 
the mouse tail vein to model bacteremia. Each mouse received 5 x 107 CFU of inoculum. The 
competitive index was calculated for the spleen and liver 24 hours after infection. The 
DcbsF/schF0 had a slight competitive disadvantage in both the spleen and liver (log CI, <0) 
(Figure 3.7A).  
Mice were also mono-challenged with WT and the double mutant to determine how the 
mutant persisted in the bloodstream independently. Bacterial burdens were calculated after 24 
hours in the liver and spleen. DcbsF/schF0 had significantly less recovered bacteria compared to 
wildtype in both the spleen and liver (Figure 3.7B, C). These results suggest that the effects of 










Figure 3.7. The DcbsF/schF0 mutant was slightly attenuated in the murine bloodstream. 
(A) CBA/J mice were infected with 5 × 107 CFU/mouse in a 1:1 mixture of the wild type and the 
DcbsF/schF0 double mutant via the tail vein. Mice were euthanized at 24 h and the spleen and 
liver were collected from each mouse. Organs were homogenized. Homogenates were diluted 
and selectively plated. The relative fitness for the mutant was compared to that of the wild type 
and calculated as a competitive index (CI). The solid black line represents a CI of 1.0, meaning 
that the two strains competed equally. Solid grey lines represent median CI. Statistics were 
calculated using the Wilcoxon signed-rank test with a theoretical median of 0. (B,C) Mice were 






































































euthanized 24 h post inoculation. Spleens (B), and livers (C) were collected and homogenized. 
Homogenates were diluted and plated. The dotted line indicates the limit of detection. 








































Here I demonstrate that UMH9 has two siderophore gene clusters found by RNA-
sequencing analysis (Figure 3.1), and upon mutation of the NRPS machinery in both loci, growth 
was inhibited under iron-limited conditions (Figure 3.2). However, despite this defective growth, 
the double NRPS mutant still excreted intact serratiochelin to wild type levels (Figure 3.6). 
Additionally, I show that this mutation may affect UMH9 fitness and its ability to infect the 
murine bloodstream. This is the first description of a potential novel role for the NRPS 
machinery in the context of gram-negative infections. Prior to these results, NRPSs were not 
thought to have a significant role outside of small molecule synthesis; however, the findings 
within this chapter suggest otherwise.     
The double DcbsF/schF0 had interesting phenotypes that prompt several hypotheses. 
Both single mutants show phenotypes similar to that of WT in all experiments which is not 
surprising given that when knocking out one siderophore locus or the other, there is potential 
redundancy and compensation from the other gene cluster. However, in this case, the double 
mutant still produces intact serratiochelin yet struggles to grow in iron limitation. This suggests 
novel complementary roles of the CbsF and SchF0 proteins that when deleted together, can no 
longer be performed. Taking the CAS and iron-limited growth results alone, I hypothesized that 
the double mutant was excreting siderophore precursor molecules that bind up the extracellular 
iron, but are less able to be used by the bacterium. This would account for the increased iron 
chelation seen and the defective growth in iron-poor medium. However, upon analysis of 
bacterial supernatants by mass spectrometry, it became clear that precursor molecules were not 
responsible for these phenotypes as intact serratiochelin was being produced in the double 
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mutant. This raises questions regarding the produced serratiochelin; is it defective in some way 
that the bound iron can’t be used? Or, is there a siderophore transport issue in the double mutant 
either bringing in too much iron or not enough? Both would result in poor growth. This suggests 
that cbsF and schF0 have a yet to be determined role in transport. Furthermore, these findings 
suggest that serratiochelin is continually being produced, resulting in increased CAS activity, 
because internal iron levels are too low to cause Fur repression of iron uptake gene expression. 
NRPSs have been long appreciated for their essential role in siderophore synthesis. The 
NRPS biochemical pathway used in siderophore elongation by amino acid transfer and 
attachment has been extensively studied in the context of many siderophores including 
enterobactin, vibriobactin, yersiniabactin, etc. While schF0 is not the only NRPS component in 
the serratiochelin locus; sch is unique in that the schF0 NRPS component is completely skipped 
in the biosynthesis of serratiochelin as shown by my mass spectrometry results and also reported 
by Seyedsayamdost. The schF0 element contains a termination domain with similarity to entF 
found in the enterobactin biosynthesis pathway responsible for incorporating an L-Serine into the 
enterobactin structure. Interestingly, the results from Seyedsayamdost et al. show evolutionary 
mixing and matching of the enterobactin and vibriobactin loci to form the serratiochelin locus. 
The enterobactin related genes seem to mainly be involved in the formation of earlier molecules 
in the pathway while the vibriobactin cluster mostly makes up the NRPS machinery involved 
later in the pathway [108]. This prompts the question of what role schF0 plays, if any. 
Previous studies looking at enterobactin production and transport have shown EntF and 
other NRPS components to be associated with the bacterial membrane despite being cytoplasmic 
proteins. These studies found EntF in membrane preparations and in the periplasmic space, 
potentially suggesting that these NRPS elements play a role in siderophore excretion and 
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transport. The authors also postulated that EntF along with other NRPS proteins might associate 
with cytoplasmic membrane pumps [16, 138]. These studies support my hypothesis that CbsF 
and SchF0, EntF homologs, could be involved in serratiochelin transport across either the outer 
membrane, periplasm, or cytoplasmic membrane.  
More work is required to confirm this hypothesis starting by determining the location of 
CbsF and SchF0 with membrane fractionation. This would then inform what proteins CbsF and 
SchF0 are potentially interacting with in the transport pathway, requiring protein-protein 
interaction studies. If they’re found in the outer membrane, CbsF and SchF0 could be 
chaperoning transport through the receptor itself. The periplasm and cytoplasmic membranes 
would suggest potential interaction with the TonB complex or the ATP powered complexes such 
as the S. marcescens FepBCGD/FhuABCD homologs that carry molecules across the inner 
membrane. It should also be determined if serratiochelin is reentering the bacterium at all after 
excretion, and at what step in transport it is blocked. Complementation studies should also be 
performed to confirm that the phenotype is rescued when both cbsF and schF0 are 
complemented individually into the double mutant background. This would confirm a 
redundancy hypothesis.      
An alternative hypothesis is the possible role in regulation of cbsF and schF0. These 
genes may feedback to the ferric uptake regulator (Fur), signaling to turn off siderophore 
production once iron requirements are met. Without this signal, there is constant siderophore 
production leading to too much iron, generating toxic superoxide radicals, and thus defective 
growth. Another hypothesis is that the ferri-siderophore is being transported, but the iron is 
unable to be accessed once inside the bacterium. 
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To conclude, while this chapter had the initial intention of determining how S. 
marcescens UMH9 siderophores contribute to pathogenesis, it uncovered something unexpected: 
a potential redundancy of two NRPS genes and a novel role in iron acquisition outside of 
biosynthesis. Even though much more work is left to fully understand the underlying mechanism 
behind the results presented here, these findings challenge our typical understanding of how 
NRPSs function and the role they play in bacterial pathogenesis. 
   
Methods and Materials 
 
Bacterial Strains and Culture Conditions 
All Serratia marcescens strains used in this study are described in Table 3.1. Luria broth 
(10 g/L tryptone, 5 g/L yeast extract, 0.5 g/L NaCl) was used for routine culture of bacteria. 
Antibiotics were added to cultures at the following concentrations when appropriate: kanamycin 
(25 µg/ml), chloramphenicol (30 µg/ml), spectinomycin (100 µg/ml). 2,2’-dipyridyl (Sigma-
Aldrich), an iron chelator, was added to LB cultures at the indicated concentrations to achieve 
iron limitation. M9 defined medium (0.1 mM CaCl2, 1mM MgSO4, 0.4% glucose) was used to 
culture bacteria for mass spectrometry. M9 was treated with Chelex-100 to remove iron, creating 










Table 3.1. S. marcescens strains and plasmids 
Name Relevant 
genotype 




   
UMH9 Wild type Bloodstream infection isolate [98] 
ΔcbsF cbsF::kan 
 
Deletion of gene 08800, cbsF, replaced 




Deletion of gene 22010, schF0, replaced 





Double mutant with both gene, cbsF and 
schF0, deletions replaced with the indicated 
antibiotic cassette.  
This study 
Plasmids    
pKD4  Source of kanamycin resistance gene [139] 
pKD3  Source of chloramphenicol resistance gene [139] 

















The lambda red recombinase system was used to make mutations in the cbsF and schF0 
loci. Using pKD4 and pKD3, the kanamycin and chloramphenicol resistance cassettes, 
respectively, were PCR amplified using primers with ~50 bp homology to the 5’ end of the gene 
locus and ~20 bp of homology to the pKD3/4 3’ end of the primer. Primers used are listed in 
Table 3.2. PCR products were digested with DpnI and electroporated into UMH9 cells harboring 
pSIM19 after heat treatment for 20 minutes at 42C. pSIM19 was removed from the mutants 

















Table 3.2. Primers for mutant constructiona 













aPrimer sequences are listed 5’ to 3’. Underlined sequences in mutant construction primers are 
















Preparation of Samples for Mass Spectrometry 
Bacterial samples were cultured overnight in LB medium with the appropriate antibiotics. 
Samples were harvested and washed in M9 minimal medium the following day, then inoculated 
into overnight cultures consisting of M9 minimal medium that had been treated with Chelex 100 
to remove iron or M9 defined medium that had 36 µM of FeSO4 added. Supernatants were 
collected by centrifugation the next day. Extraction and mass spectrometry was performed by the 
University of Michigan Natural Products Discovery Core as described in Appendix A.  
 
Measuring siderophore production on CAS agar. 
UMH9 and the mutant strains were cultured overnight in LB medium and collected by 
centrifugation the following day. Bacteria were washed in M9 minimal medium, then inoculated 
1:100 into M9 minimal medium overnight cultures with the iron removed. The next day, cultures 
were OD matched and 5uL were spotted onto chrome azurol S (CAS) agar prepared as 
previously described [141]. Plates were incubated for two days at 37C. A color change from blue 
to yellow was observed on the plates in a circle around the point of inoculation. The diameter of 
the circle was measured to quantify siderophore production.    
 
Growth in Iron-Depleted Medium 
Bacterial growth was evaluated in several iron-limited conditions in both defined and 
undefined media. First, bacterial growth was measured in M9 minimal medium after treatment 
with Chelex 100 to remove iron. After initial overnight growth in LB medium, bacterial cultures 
were centrifuged and pellets were washed twice, then resuspended in M9 defined medium. 3uL 
was used to inoculate each well of a Bioscreen growth plate to an OD600 of 0.01. The medium 
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consisted of M9 medium after Chelex treatment, Chelex treated M9 medium but FeSO4 added 
back at the indicated concentration, M9 medium without Chelex treatment, and M9 medium 
without Chelex treatment but FeSO4 added back at the indicated concentration. Plates were 
incubated at 37°C with continuous shaking, and the OD600 was measured every 15 min for 21 h 
using a BioScreenC plate reader. 
Iron-limited conditions were also created in LB undefined medium by adding 2,2 
dipyridyl, an iron chelor. Samples were prepared as above, but inoculated 1:100 into 3mL of LB 
with the indicated concentration of dipyridyl. OD600 measurements were taken every hour using 
a spectrometer (BioTek). IC50 concentrations were determined using a nonlinear regression 
calculation.   
 
RNA Purification and Quantification of Gene Expression by qRT-PCR 
UMH9 WT was grown overnight in LB medium, harvested the following day, and 
washed in LB supplemented with 2,2 dipyridyl at 200 µM. Washed bacteria were subcultured 
1:10 into LB medium with and without 200 µM dipryidyl. Cultures were incubated at 30C. 
When an OD600 between 0.4-0.5 was reached, 2 volumes of RNA Protect was added to the 
cultures and incubated at room temperature for five minutes. Samples were centrifuged for 10 
minutes (5,000 xg) at 4C. Supernatants were decanted and excess RNA Protect was removed. 
Bacteria were lysed using lysozyme and proteinase K. The RNAeasy minikit was used to purify 
RNA by the manufacturer’s instruction. Samples were DNase treated to remove DNA from the 
RNA samples. RNA was repurified following the RNAeasy minikit protocol.  
cDNA was synthesized by mixing 1µg of RNA, 1 U random hexamers, and 10mM 
dNTPs,  and incubating at 65C for five minutes then cooled on ice to room temperature. Reverse 
 73 
transcription was performed by adding 200 U Superscript III reverse transcriptase and 1 u 
RNaseOUT. Remaining RNA template was removed using 1µL of RNAseH added to samples 
and incubated at 37C for 30 minutes. cDNA was purified using the Epoch PCR Clean up Kit.   
qPCR was performed to compare iron gene expression in culture conditions with and 
without dipyridyl. 1ng of template cDNA was aliquoted per reaction and expression of each gene 
was measured in triplicate. Primers were constructed to amplify a ~100-bp internal region of the 
target gene. gyrB was used as the internal control and a no template control was included as the 
negative control. Brilliant III Ultra-Fast SYBR green (Agilent) was used to detect product 
amplification on a QuantStudio3 qPCR system. Relative gene expression was calculated using 
the delta, delta CT method.  
 
Bacteremia Mouse Model 
Overnight cultures of WT and the DcbsF/schF0 mutant were harvested by centrifugation 
(3,500 × g for 30 min at 4°C) and resuspended in phosphate-buffered saline (PBS) to a density of 
5 × 108 CFU/ml. Two groups of 10 female CBA/J mice (Jackson 000656) aged 6 to 8 weeks were 
independently inoculated with either UMH9 WT or ΔcbsF/schF0. An inoculum (100 µL) of 
5 × 108 CFU/ml was injected into the tail vein. Infection was allowed to progress for 24 h [137]. 
Mice were euthanized by anesthetic overdose. Spleen and liver were collected and homogenized 
in PBS. Homogenates were diluted and plated onto LB agar or LB agar containing the 
appropriate antibiotics using an Autoplate 4000 spiral plater (Spiral Biotech) and incubated 
overnight at 37°C. Bacterial colonies were counted the following day using a QCount 
(Chemopharm). For cochallenge experiments, the following modifications were made. The 
ΔcbsF/schF0 mutant strain was combined in a 1:1 mixture with the UMH9 WT strain at 
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5 × 108CFU/ml. Competitive indices were calculated using the following equation: log10 [(CFU 
of mutant/CFU of wild type) output/(CFU of mutant/CFU of wild type) input]. All animal 




The Serratia marcescens Siderophore, Serratiochelin, is Necessary for Full 
Virulence during Bloodstream Infection
 
Notes. The material presented in this chapter was adapted from the following article: 
 
Weakland DR, Smith SN, Bell B, Tripathi A, Mobley HLT. The Serratia marcescens 
Siderophore Serratiochelin Is Necessary for Full Virulence during Bloodstream Infection. Infect 
Immun. 2020; 88(8): e00117-20. Published 2020 Jul 21. doi:10.1128/IAI.00117-20 
 
The introduction and figure numbers have been updated to conform to the dissertation. 
Otherwise, the text remains as published with minor editorial changes.  
 
Abstract.  
Serratia marcescens is a bacterium frequently found in the environment, but over the last several 
decades has evolved into a concerning clinical pathogen, causing fatal bacteremia. To establish 
these infections, pathogens require specific nutrients—one very limited but essential nutrient is 
iron. After characterizing the iron acquisition systems in S. marcescens isolate UMH9, which 
was recovered from a clinical bloodstream infection using RNA-sequencing (RNA-seq) in 
Chapter II, we honed in on two predicted siderophore gene clusters (cbs and sch) that were 
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regulated by iron. Mutants were constructed to delete each iron acquisition locus individually 
and in conjunction, generating both single and double mutants for the putative siderophore 
systems. Mutants lacking the sch gene cluster lost their iron-chelating ability as quantified by 
chrome azurol S (CAS) assay, whereas the cbs mutant retained wild type activity. Mass 
spectrometry-based analysis identified the chelating siderophore to be serratiochelin, a 
siderophore previously identified in Serratia plymuthica. Serratiochelin-producing mutants also 
displayed a decreased growth rate in iron-limited conditions created by dipyridyl added to LB 
medium. Additionally, mutants lacking serratiochelin were significantly outcompeted during co-
challenge with wild type UMH9 in the kidneys and spleen after inoculation via the tail vein. This 
result was further confirmed by an independent challenge in a bacteremia mouse model, 
suggesting that serratiochelin is required for full S. marcescens pathogenesis in the bloodstream. 
Nine other clinical isolates have at least 90% protein identity to the UMH9 serratiochelin system; 













Iron is intrinsically important for nearly all cellular life as it serves as a cofactor for 
processes involved in DNA replication, ATP generation, and electron transfer. As such, 
acquiring iron is necessary for bacterial pathogen survival and virulence; however, mammals 
tightly regulate free iron levels by binding up iron in circulating proteins such as ferritin, 
transferrin, and heme [126, 127]. Bacteria overcome these low levels of available iron by 
synthesizing and secreting small molecules called siderophores. Siderophores scavenge ferric 
iron found in the extracellular space by stripping host proteins of their bound iron [111, 127]. 
Bacteria encode specific transporters to import the siderophore-bound iron across the membrane 
and into the cytoplasm where iron is released by dedicated proteins.  
Siderophores have been characterized as virulence factors in many bacterial species 
including E. coli, and Klebsiella pneumoniae [18, 19, 100]. However, for many emerging 
pathogens, siderophores and their contribution to infection have not been characterized. One 
such pathogen is Serratia marcescens. Once in the blood, S. marcescens quickly disseminates 
resulting in multi-organ failure and high rates of mortality [142]. To establish these clinically 
important infections, S. marcescens requires an adequate supply of iron; however, the systems 
that contribute to iron acquisition have not been thoroughly studied.         
  In the previous chapter, the initial goal was to elucidate how Sm siderophores contributed 
to pathogenesis in the bloodstream. Two potential siderophore loci (cbs and sch) were identified 
by RNAseq (Chapter II) and deletion mutants in components of the NRPS machinery were 
constructed. A cbsF mutant was made in the cbs locus, the schF0 gene was deleted in the sch 
locus, and then a double mutant deleting both cbsF and schF0 together. Growth of these mutants 
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was tested in iron-limited conditions. Both the cbsF and schF0 mutants grew comparably to the 
WT strain; however, cbsF/schF0 had severely defective growth in these conditions, suggesting 
redundant roles of the individual siderophores resulting in a phenotype that was only evident 
when both NRPS components were deleted most likely due to insufficient iron uptake. However, 
when cultured on CAS agar to measure iron chelation, the double mutant had notably more 
siderophore production than the cbsF mutant, schF0 mutant, and WT. The cbsF and schF0 
mutants showed siderophore production comparable to the WT. Then, mass spectrometry 
confirmed usable serratiochelin was present in all mutant supernatants. These results suggest that 
even though serratiochelin is being produced in the double mutant, it cannot be utilized by the 
bacterium. Since the single mutants perform comparably to the WT, this suggests that cbsF and 
schF0 have redundant roles in serratiochelin transport potentially modifying the siderophore 
upon reuptake, challenging canonical ideas of NRPS function.  
Given the results of the preceding chapter, Serratia iron acquisition is more complicated 
than initially appreciated and more work is required to understand the possibility of NRPS 
redundancy and function in siderophore transport. However, in this chapter, to answer the 
original question of how Sm siderophores affect its pathogenesis, full cbs and sch operon 
knockouts were constructed to ensure disruption of siderophore synthesis. Mutants lacking the 
full sch locus lost iron-chelating ability quantified by the CAS assay, compared to iron chelation 
observed in the wild type and full cbs locus mutant. Similar to Chapter II results, mass 
spectrometry analysis identified the chelating siderophore to be serratiochelin. Mutants lacking 
serratiochelin were significantly outcompeted during co-challenge by wild type UMH9 in the 
kidneys and spleen. This result was further confirmed by independent challenge in a bacteremia 
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Characterization of two putative siderophore operons.  
The two identified siderophore gene loci are organized in potential operons and appear 
distinct as they contain unique gene compositions relative to one another and are located in 
different regions of the chromosome. The first putative operon (referred to as cbs) is 13,859 base 
pairs and has fewer genes than what is typical of a pathogen-associated siderophore locus [110]. 
cbs encodes a TonB-dependent receptor (gene tag: BVG96_RS08815) as well as an exporter 
(BVG96_RS08795) presumably for the molecule it produces. The majority of this operon is 
comprised of a single predicted non-ribosomal peptide synthetase (NRPS) (BVG96_RS08800)-
encoding gene (Figure 4.1A). Genes within the cbs operon have similarity (four corresponding 
genes have >60% amino acid identity) to the chrysobactin locus of Dickeya dadantii 3937 and 
previous studies have reported that certain S. marcescens strains produce chrysobactin (Figure 
4.1B) [107]. However, this operon lacks several essential genes in the chrysobactin biosynthesis 
pathway such as an isochorismate synthase, a 2,3-dihydroxybenzoate-AMP ligase, an 
isochorismatase, and a 2/3-dihydro-2,3-dihydroxybenzoate dehydrogenase. These genes are 
encoded elsewhere in the UMH9 genome, several of which are found in the second identified 
operon [110].  
The second putative operon (referred to as sch) is much larger than the first (27,686 base 
pairs) and appears to contain all genes predicted for the complete biosynthetic pathway of a 
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NRPS-dependent siderophore including genes required to encode enzymes that could synthesize 
siderophore precursor molecules, and the obligate NRPS [16]. Additionally, sch encodes two 
TonB-dependent receptors as well as an exporter. The composition of the sch genetic region is 
more typical of a pathogen-associated siderophore and displays similarity to components of the 
serratiochelin biosynthetic operon of S. plymuthica (10 genes have over 65% identity) (Figure 
4.1C). Serratiochelin, a Serratia-specific siderophore, was first identified in S. marcescens TW 
[107]. The biosynthesis pathway has been described in Serratia spp. V4 by predicting 
evolutionary mixing of the vibriobactin and enterobactin biosynthetic operons to produce 
serratiochelin [108]. While the UMH9 sch operon is not identical to the operon in Serratia spp. 
V4, we nevertheless predict that UMH9 uses this similar biosynthetic pathway to produce 
serratiochelin. Interestingly, some of the biosynthetic genes missing from cbs are present in sch 
suggesting that the ability of cbs to encode synthesis of a siderophore may be dependent on sch 
(Figure 4.2). Due to the similarity of these genetic regions to reported chrysobactin and 
serratiochelin loci, the putative siderophore operons are heretofore referred to as cbs and sch, 






Figure 4.1. Siderophore locus 1 (cbs) is similar to the chrysobactin operon in Dickeya 
dadantii while Siderophore locus 2 (sch) shows similarity to Serratia plymuthica 
serratiochelin genes. 
A) The UMH9 cbs locus has an organization similar to the chrysobactin operon found in Dickeya 
dadantii (B). Four genes (in blue) are missing from the UMH9 cbs locus that are present in the 
D. dadantii chrysobactin operon. However, these genes, involved in the production of 
chrysobactin precursor molecules, are found elsewhere in the UMH9 genome. The percentages 
reported underneath the genes in panel B are the protein percent identity to the UMH9 
Siderophore Locus 1 corresponding gene in panel A. C) The UMH9 sch locus contains genes 
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Siderophore Locus 2 (sch) of Serratia marcescens UMH9

































predicted to be necessary for siderophore biosynthesis and transport. The percentages reported 
under the genes in panel C are the amino acid percent identity to the S. plymuthica serratiochelin 
locus corresponding gene. The gene function is noted above each arrow. The UMH9 locus tag 
number (BVG96_RS…) is referenced below each arrow for panels A and C. Red triangles 
indicate the location of putative ferric uptake regulator (Fur) binding sequences in the UMH9 
genome. The genes located between the vertical hashed lines in panels A and C were deleted in 



















Loss of sch abrogates iron-chelation in S. marcescens.  
Each siderophore locus was disrupted individually (cbs::kan [Δcbs], sch::kan [Δsch]) and 
in combination (cbs::cam sch::kan [Δcbs/sch]) in the parent strain UMH9 (WT). In each case, 
the entire siderophore-encoding locus was deleted and replaced with a kanamycin or 
chloramphenicol resistance cassette. To determine how each locus contributes to siderophore 
production, the wild type strain and each construct were cultured overnight in iron-depleted M9 
minimal medium or M9 medium supplemented with 36µM FeSO4. Culture supernatants were 
used in a soluble CAS assay the following day to quantify siderophore synthesis. As expected, 
the WT strain and deletion constructs showed no siderophore production under iron-replete 
conditions (Figure 4.2). Conversely, WT showed the greatest amount of CAS activity under iron-
limitation. CAS activity comparable to WT was observed for the Δcbs mutant. However, 
significant loss of iron chelation activity was observed in the Δsch and Δcbs/sch mutants. These 
results suggested that under iron-limitation, UMH9 produces a siderophore that can chelate iron 










Figure 4.2. The sch locus is responsible for detectable siderophore production. 
Siderophore production was quantified by liquid chrome azurol S (CAS) assay on bacterial 
supernatants. Bacteria were cultured overnight in M9 minimal medium with (black bars) or 
without (grey bars) 36µM FeSO4. 10µM EDTA serves as the positive control for iron-limitation. 
Low absorbance (A630) values indicate more siderophore production. Shown is the mean of three 
independent replicates and error bars represent standard error of the mean. Significant 

















































Mass spectrometry reveals that the sch operon produces serratiochelin A.  
Because the siderophore produced by the sch locus is responsible for detectable CAS 
activity, we wanted to definitively identify the siderophore being produced by the sch locus 
using mass spectrometry (MS). Wild type UMH9 and the three siderophore mutants, Δcbs, Δsch, 
and Δcbs/sch, were cultured overnight in both iron-depleted M9 minimal medium and M9 
medium supplemented with 36µM FeSO4. MS was performed on bacterial supernatants as 
described in Chapter III. Fragmentation patterns matching serratiochelin A were identified in 
samples WT –Fe, and Δcbs –Fe and absent in samples Δsch +Fe, Δsch –Fe, Δcbs/sch +Fe, and 





Figure 4.3. Serratiochelin A production is lost in a sch mutant. 
An intensity plot of serratiochelin A was generated using mass spectrometry performed on the 
supernatants of the indicated strains after overnight culture in M9 minimal medium with and 
without iron (where indicated). A directed approach identified serratiochelin A with a retention 
time of 4.84 minutes to be associated with the sch operon. The molecular structure of 
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cbs cbs sch sch cbs/sch cbs/sch
ND ND ND ND ND ND
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Serratiochelin A is necessary for growth under iron-limitation in vitro.  
Mass spectrometry results indicated that the sch locus encodes enzymes required to 
synthesize serratiochelin A and serratiochelin is most likely responsible for iron chelation as 
indicated by the CAS assay. A very low concentration of chrysobactin was present in wild type 
supernatants by mass spectrometry associated with the cbs locus (data not shown). Unlike the 
sch locus, chrysobactin did not demonstrate any notable iron chelation by CAS assay, likely due 
to its low concentration. Based on these results, we hypothesized that in vitro growth under iron-
limiting conditions would be contingent on the presence of the sch locus that encodes enzymes 
required for serratiochelin A production.  
To test this, increasingly iron-limited conditions were established by titrating dipyridyl 
into LB. UMH9 WT, Δcbs mutant, Δsch mutant, and the Δcbs/sch double mutant all grew 
similarly in LB medium without dipyridyl (Figure 4.4A). As dipyridyl concentrations increased, 
all strains exhibited less growth, as expected (Figure 4.4). WT and the Δcbs mutant had 
comparable growth in 200µM dipyridyl, while the Δsch and Δcbs/sch mutants displayed 
noticeably inhibited growth (Figure 4.4B). At 250µM (Appendix A, Figure A.2A) and 300µM 
(Figure 4.4C) dipyridyl concentrations, the Δsch and Δcbs/sch mutants showed notably decreased 
growth compared to the WT and Δcbs mutant. The Δcbs mutant had the most robust growth 
under these conditions while WT had mildly decreased growth compared to the Δcbs mutant. 
The Δsch and Δcbs/sch mutants failed to grow at dipyridyl concentrations of 350µM (Appendix 
A, Figure A.2B) and 400µM (Figure 4.4D). The Δcbs mutant continued to display the best 
growth under these concentrations. The WT had abrogated growth at 350µM dipyridyl and 
minimal growth at 400µM dipyridyl. Because the mutants lacking the sch locus struggled to 
grow under these conditions, the half maximal inhibitory concentration (IC50) of dipyridyl for the 
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Δsch and Δcbs/sch mutants was notably lower than the IC50 for the WT and Δcbs mutant (Figure 
4.4E).  
These results suggested that the sch locus is essential for growth under these iron-limited 
conditions. Without sch, UMH9 is much more inhibited by dipyridyl iron-limitation than the WT 
strain. Interestingly, the absence of cbs appears to provide a growth advantage in UMH9. 
Additionally, because the Δcbs/sch mutant shows severely inhibited growth comparable to that 
seen in the Δsch mutant, the inhibited growth related to the loss of sch cannot be overcome by 


































































































S. marcescens UMH9 wild type, the cbs locus mutant (Δcbs), the sch locus mutant (Δsch), and 
the cbs/sch double loci mutant (Δcbs/sch) were inoculated into LB medium containing 0µM (A), 
200µM (B), 300µM (C), or 400µM (D) dipyridyl after culture overnight in LB with 250µM 
dipyridyl. Cultures were incubated with aeration at 37˚C and OD600 readings were taken every 15 
minutes to measure bacterial growth. The mean of three independent replicates is shown. (E) The 
half maximal inhibitory concentration (IC50) of dipyridyl was calculated for each mutant based 



















Serratiochelin is required for growth in human serum.  
Although both cbs and sch affect growth in LB culture with dipyridyl, the importance of 
these genes in vivo remained to be determined. To explore their role in a physiologically relevant 
iron-limited condition, we first assessed the wild type and mutant growth in 100% heat-
inactivated human serum (Figure 4.5). Iron bound to transferrin is the principal iron carrier in the 
blood and the main source of iron in human serum [143]; therefore, we hypothesized that the 
ability to produce a siderophore would be advantageous to growth in this medium.  
The WT strain and the three mutants displayed an initial decrease in optical density likely 
due to bacterial aggregation during the lag phase (Figure 4.5A). Eventually, the bacterial 
aggregates dispersed and logarithmic growth was observed. WT began to grow after nearly eight 
hours while Δcbs, Δsch, and Δcbs/sch mutants showed growth at ten hours. After initial growth at 
ten hours, Δsch and Δcbs/sch mutants reached the stationary phase at approximately 16 hours, 
whereas the WT and Δcbs strains grew beyond 20 hours. The final OD600 was significantly 
higher in WT and Δcbs compared to the final OD600 of Δsch and Δcbs/sch mutants (Figure 
4.5B).       
These results suggest that the sch locus contributes to the growth of S. marcescens in 
human serum. Taking growth in serum with the growth in dipyridyl conditions together, the cbs 
operon appears dispensable for growth under iron-limitation and does not contribute significantly 
to growth even in physiologically relevant iron-limited conditions.        
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Figure 4.5. Serratiochelin mutants grow poorly in human serum. 
(A) S. marcescens UMH9 wild type, Δcbs, Δsch, and Δcbs/sch mutants were cultured in 100% 
heat-inactivated human serum at 37°C with aeration. OD600 readings were taken every 15 
minutes to measure bacterial growth. Data represent the means from three independent 
replicates. (B) Serratiochelin mutants have significantly lower final stationary phase OD600 
measurements compared to wild type in human serum. S. marcescens UMH9 wild type, Δcbs, 
Δsch, and Δcbs/sch mutants were cultured in 100% heat-inactivated human serum at 37°C with 
aeration. Final stationary phase OD600 of the above strains at 21 hours was compared. Shown is 
the mean of three-independent replicates and error bars represent standard error of the mean. 
Significant differences (***, p<0.001; ****, p<0.0001) were determined using a two-tailed 
































Figure S3: Endpoint growth in 100% human serum















Mutants lacking sch are attenuated during bacteremia.  
Siderophores have been found to contribute significantly to virulence in murine models 
of infection [19], and since I had different in vitro results with the full operon knockouts as 
compared to the single gene deletions in Chapter III, I decided to revisit the mouse model. Since 
serratiochelin was essential for growth in the low iron medium in vitro, we hypothesized that it 
would contribute to its pathogenesis in the bloodstream. Using a murine model of bacteremia 
adapted from use with E. coli [137], we evaluated the fitness of the siderophore mutants in the 
bloodstream using competition experiments. We prepared a 1:1 mixture of each siderophore 
mutant with UMH9 WT, and then co-inoculated mice with 5 x 107 CFU of this suspension via 
the tail vein. Competitive indices (CI) of mutant and wild type bacteria were calculated in the 
kidneys, spleen, and liver 24 hours post-infection (hpi). The Δsch and Δcbs/sch mutants 
displayed a significant competitive disadvantage (log CI, < 0) in the kidney (Figure 4.6A) and 
spleen (Figure 4.6B) with a modest disadvantage observed in the liver (Figure 4.6C). The Δcbs 
mutant competed equally with wild type in the spleen and liver (log CI, = 0) (Figure 4.7B, 4.6C), 
but a competitive advantage was observed in the kidney (log CI, > 0), suggesting that loss of the 
cbs locus was advantageous to kidney colonization (Figure 4.6A). These results echo my earlier 
in vitro findings and suggest that serratiochelin is necessary for complete fitness in the 
bloodstream. 
Although the entire sch gene cluster, including the serratiochelin receptor gene, was 
deleted, we hypothesized that serratiochelin produced by the wild type strain may have partially 
cross-complemented the mutant strains since the mutants retained genes that were annotated as 
encoding putative orphan siderophore receptors. Therefore, we performed independent infections 
with each strain, enumerating bacterial burden in the kidneys, spleen, and liver, 24 hpi. Mutants 
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lacking sch (Δsch and Δcbs/sch) had significantly fewer CFUs recovered from the kidney 
compared to the wild type and the Δcbs mutant (p<0.0007), suggesting that mutants unable to 
produce serratiochelin are attenuated in the kidney (Figure 4.7A). The Δcbs/sch mutant colonized 
the spleen significantly less well than WT (Figure 4.7B). The presence or absence of 
serratiochelin did not appear to affect colonization in the liver (Figure 4.7C). Since sch mutants 
were attenuated in both co-challenge and independent challenge experiments, this rules out that 
the wild type strain contributed to any significant cross-feeding of the sch mutant during co-
challenge. Together, these data indicate that serratiochelin is required for full pathogenicity in 












Figure 4.6. Fitness of UMH9 siderophore mutants in a murine model of bacteremia. 
CBA/J mice were infected with 5 x 107 CFU/mouse in a 1:1 mixture of wild type and the 
indicated mutant strain via the tail vein. Mice were euthanized at 24 hours and kidney (A), spleen 
(B), and liver (C) were collected from each mouse. Organs were homogenized. Homogenates 
were diluted and selectively plated. The relative fitness for each mutant compared to the wild 
type was calculated as a competitive index (CI). The dotted line represents a CI of 1.0, meaning 
the two strains compete equally. Solid lines represent median CI. Statistics were calculated using 
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Figure 4.7. Independent infections of UMH9 siderophore mutants in a murine model of 
bacteremia. 
CBA/J mice were independently inoculated with the indicated strain via the tail vein. Mice were 
euthanized 24 hours post-inoculation. Kidneys (A), spleens (B), and livers (C) were collected 
and homogenized. Homogenates were diluted and plated. The dotted line indicates the limit of 
detection. Significance determined by the Mann-Whitney test is indicated with an asterisk (*, 





















































































The characterized siderophore operons are conserved across clinical isolates of S. 
marcescens.  
S. marcescens is a diverse species with a core genome of 3,372 genes and an accessory 
pangenome consisting of 10,215 genes [144]. To determine whether the two putative siderophore 
loci are conserved among S. marcescens strains, we used PATRIC to compare predicted protein 
sequence similarity of nine clinical bloodstream isolates of S. marcescens to UMH9 [145]. We 
found that genes within the cbs and sch loci are conserved and individual predicted proteins 

















Figure 4.8. The cbs and sch genetic regions are conserved among clinical isolates of Serratia 
marcescens. 
The amino acid sequences of the UMH9 siderophore loci were compared to the siderophore loci 
of nine other bacteremic isolates of Serratia marcescens. Using PATRIC’s online protein 

















































































The contribution of siderophores to infection has been well established for a large 
number of bacterial pathogens [22, 111, 124, 146]. However, because S. marcescens was thought 
to largely reside in environmental reservoirs, we aimed to determine the importance of Serratia 
siderophores to infection within the mammalian host. Prior to this work, S. marcescens 
siderophore systems had not been described in bacteremia infection models relevant to human 
disease. Two identified siderophore operons had been reported previously; however, this is the 
first study detailing their up-regulation under iron-limited conditions (Chapter II) as well as their 
contribution to S. marcescens pathogenesis. We demonstrate that serratiochelin A is produced by 
the sch locus and sch is necessary for S. marcescens UMH9 to grow under iron-limiting 
conditions both in vitro (Fig. 4.4, Fig. 4.5) and in vivo (Fig. 4.6, Fig. 4.7). The cbs locus is 
dispensable for infection and does not significantly contribute to growth under iron limitation. 
Indeed, under some conditions, the expression of cbs seems to limit UMH9 growth. However, 
despite the different contributions to fitness between the two siderophore loci in the conditions 
tested here, both are highly conserved among other sequenced clinical isolates. 
S. marcescens occupy broad environmental niches beyond the mammalian host as it also 
infects insects and survives in aquatic environments [99]. Because the cbs locus is dispensable in 
the mammalian model of infection, we speculate that cbs might be important for S. marcescens 
survival in the environment rather than within the host. The UMH9 cbs locus encodes proteins 
that share close amino acid similarity to those encoded by the chrysobactin operon in the plant 
pathogen, Erwinia chrysanthemi (Dickeya dadantii). Chrysobactin, a virulence factor for E. 
chrysanthemi, is responsible for pathogen dissemination throughout the host plant [109]. 
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Therefore, cbs may contribute to pathogenesis in environmental niches and chrysobactin 
production may be dependent on an unknown environmental cue; however, it does not 
significantly contribute to pathogenesis within the mammalian host.  
Additionally, despite the increased expression of genes in the cbs locus under iron 
limitation, there is little detectable chrysobactin. And in fact, the cbs mutant conferred a growth 
advantage under some conditions compared to wild type growth. We do not believe this growth 
advantage is related to increased serratiochelin production when the cbs locus is deleted because 
the mass spectrometry results showed comparable serratiochelin levels in wild type and cbs 
mutant supernatants in M9 minimal medium. We expect this is likely the case in LB medium 
with dipyridyl as well although it has not been tested. We hypothesize that synthesis of the 
enzymes encoded by cbs could be energetically costly to produce resulting in increased growth 
of the cbs mutant during iron-limitation. Interestingly, chrysobactin synthesis may be 
biosynthetically dependent on several genes within the sch locus. sch genes BVG96_RS22020, 
22025, and 22030 have similarity to chrysobactin biosynthetic genes cbsC, cbsE, and cbsB, 
respectively. These genes can be found in the D. dadantii chrysobactin operon, but are absent in 
the S. marcescens UMH9 cbs locus. These genes are involved in both serratiochelin and 
chrysobactin precursor production according to previously published biosynthetic pathways of 
these molecules [108, 110]. In strain UMH9, once these precursor molecules are produced, they 
are most likely used to produce serratiochelin. These products can also be used for chrysobactin 
synthesis, but given the small amount of chrysobactin identified in WT UMH9 supernatants, this 
most likely occurs to a lower extent. Additionally, there are possibly hurdles in efficiently 
coordinating small molecule biosynthesis across differentially regulated operons. The low level 
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of chrysobactin production could be explained by this inefficiency. However, further research is 
needed to explore possible interactions between the sch and cbs loci.  
Gram-negative pathogens can utilize siderophores made by other bacteria, a strategy 
often used in polymicrobial settings [32]. S. marcescens possesses a receptor for aerobactin, 
IutA, but does not produce aerobactin itself. It also has a receptor with similarity to FepA, an 
enterobactin transporter. Additionally, UMH9 has several orphan hypothetical siderophore 
receptors outside of the sch and cbs siderophore gene clusters suggesting its ability to import 
other potential siderophores that it does not itself produce. Therefore, considering these 
observations along with S. marcescens being a known opportunist, it is likely that S. marcescens 
depends on xenosiderophores in polymicrobial infections especially since it possesses only one 
siderophore that contributes to pathogenesis whereas other Gram-negative pathogens typically 
have two or more [18, 19]. Interestingly, it is unknown whether other Gram-negative pathogens 
can utilize serratiochelin or chrysobactin.   
S. marcescens also acquires iron from heme using two well-known systems, Hem and 
Has. Given the high concentration of heme in the bloodstream, we hypothesize that these 
systems also play a role in iron acquisition during bacteremia, which will be discussed further in 
Chapter V. Previous literature has highlighted the redundancies between the major iron 
acquisition systems in other pathogens, which may explain why we see little to no decrease in 
colonization in the mouse spleen and liver when sch is deleted [19]. In these environments, iron 
acquired from heme may be the dominant iron source, whereas, in the kidney, siderophores play 
a larger role. S. marcescens also possesses a ferric citrate transport system that was up-regulated 
during iron-limited RNA-seq experiments. Citrate is capable of binding and importing iron; 
however, its affinity for iron is weak compared to that of siderophores [22]. Nonetheless, citrate 
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has been shown to act as a siderophore and may play a redundant role in iron acquisition along 
with serratiochelin, chrysobactin, and heme uptake [119, 147]. To fully understand iron import 
during bacteremia, future studies evaluating the contribution of the heme uptake systems and 
ferric citrate import should be performed. Additionally, it is possible that heme uptake can 
compensate for siderophores, and vice versa; therefore, a mutant in which all siderophore 
systems, as well as heme systems, are deleted would be an interesting tool to evaluate the 
contribution of iron acquisition irrespective of specific systems. 
We recognize that this study examines one clinical isolate of Serratia marcescens and 
that additional isolates could possess additional iron acquisition systems. Our lab has sequenced 
the genomes of nine clinical S. marcescens strains isolated from humans with bacteremia. 
Genome comparison studies show that other S. marcescens isolates also possess 
the cbs and sch loci and have a high amino acid sequence identity to the operons found in 
UMH9. Therefore, our results may be considered broadly applicable to the virulence of 
bacteremic strains of S. marcescens. 
In summary, we have defined the iron-regulated transcriptome of S. marcescens UMH9 
to identify the full repertoire of iron-acquisition systems and components within this important 
opportunistic pathogen. We characterized the expression of two well-conserved putative 
siderophore systems (sch and cbs), identified the molecular products synthesized, and implicated 
the sch locus product, serratiochelin A, as contributing to the pathogenesis in the murine 
bloodstream. However, the cbs locus has a yet undetermined role in pathogenesis and does not 
appear to contribute to S. marcescens UMH9 virulence in mice. These findings clearly show that 
the sch product, serratiochelin, is a bona fide virulence factor during bacteremia.  
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Materials and Methods  
 
Bacterial Strains and Culture Conditions  
S. marcescens strains and plasmids used in this study are listed in Table 4.1. Bacteria 
were routinely cultured in luria broth medium (LB) (10 g/liter tryptone, 5 g/liter yeast extract, 0.5 
g/liter NaCl). Antibiotics were added to cultures at the following concentrations when 
appropriate: kanamycin (25 µg/ml), chloramphenicol (30 µg/ml), spectinomycin (100 µg/ml). 
2,2’-dipyridyl (Sigma-Aldrich), an iron chelator, was added to LB cultures at the indicated 
concentrations to achieve iron limitation. M9 defined medium (0.1 mM CaCl2, 1mM MgSO4, 
0.4% glucose) was used to culture bacteria for mass spectrometry and chrome azurol S (CAS) 
experiments [131]. M9 was treated with Chelex-100 to remove iron, creating iron-limited 















Table 4.1. S. marcescens strains and plasmids 
Name Relevant 
genotype 




   
UMH9 Wild type Bloodstream infection isolate [98] 
Siderophore 1 (cbs) cbs::kan 
(Δcbs) 
Full operon deletion from gene 08795 
to 08815, replaced with kanamycin 
cassette from pKD4. 
This study 
Siderophore 2 (sch) sch::kan 
(Δsch) 
Full operon deletion from gene 21965 
to 22035, replaced with kanamycin 
cassette from pKD4. 
This study 






Double mutant with both full operon 
deletions replaced with the indicated 
antibiotic cassette.  
This study 
Plasmids    
pKD4  Source of kanamycin resistance gene [139] 
pKD3  Source of chloramphenicol resistance 
gene 
[139] 














Construction of UMH9 Mutants  
Single and double mutations of the cbs and sch loci were constructed using the lambda 
red recombinase system [148]. PCR amplification of the kanamycin- or chloramphenicol-
resistance cassettes from pKD4 and pKD3, respectively, was performed using primers with ~50-
bp of homology at the 5’ end to the siderophore locus and ~20-bp homology to pKD3/4 at the 3’ 
end of each primer. Primers for mutant construction are listed in Table 4.2. PCR products were 
digested with DpnI (New England Biolabs), then transformed into UMH9 cells expressing 
lambda red recombinase from pSIM19 after heat treatment for 20 minutes at 42˚C. pSIM19 was 
removed from the mutant strains as described previously [148]. Mutants were confirmed by PCR 

















Table 4.2. Primers for mutant constructiona 

















aPrimer sequences are listed 5’ to 3’. Underlined sequences in mutant construction primers are 


















Growth of S. marcescens Strains 
Bacterial strains were cultured with aeration overnight in LB medium at 37˚C. The 
following day, bacteria were collected by centrifugation and washed twice with LB medium 
containing 250 µM dipyridyl. Bacteria were suspended in LB + 250 µM dipyridyl and 30 µL 
were used to inoculate 3 mL of LB + 250 µM dipyridyl for overnight cultures. A sample of 
culture (3 µL) was used to inoculate each well of a 100-well growth plate containing 300 µL of 
LB with the indicated dipyridyl concentration to an OD600 of 0.01. Growth was also measured in 
100% heat-inactivated human serum. Bacteria were cultured and loaded into the serum-
containing growth plate as described above. Growth curves were performed in biological and 
technical triplicates. Plates were incubated at 37˚C with continuous shaking and OD600 was 
measured every 15 minutes for 21 hours using a BioScreenC plate reader. Due to technical 
reasons, blank serum measurements were not subtracted from growth measurements, accounting 
for the higher starting OD600. 
 
Murine Model of Bacteremia 
Overnight cultures of WT and mutant constructs were harvested by centrifugation (3500x 
g for 30 minutes at 4˚C) and resuspended in phosphate-buffered saline (PBS) to a density of 5 x 
108 CFU/ml. Four groups of ten female CBA/J mice (Jackson 000656) aged 6-8 weeks were 
independently inoculated with either UMH9 WT, Δcbs, Δsch, or Δcbs/sch constructs. An 
inoculum (100 µL) of 5 x 108 CFU/ml was injected into the tail vein. Infection was allowed to 
progress for 24 hours, or until mice appeared moribund. Mice were euthanized by anesthetic 
overdose. Spleen, kidney, and liver were collected and homogenized in PBS. Homogenates were 
diluted and plated onto LB agar or LB agar containing the appropriate antibiotics using an 
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Autoplate 4000 spiral plater (Spiral Biotech) and incubated overnight at 37˚C. Bacterial colonies 
were counted the following day using a QCount (Chemopharm). For co-challenge experiments, 
the following modifications were made. Each mutant strain was combined in a 1:1 mixture with 
the UMH9 WT strain at 5 x 108 CFU/ml. Competitive indices were calculated using the 
following equation: log10 [(CFU mutant/CFU wild-type) output / (CFU mutant/ CFU wild-type) 
input]. All animal experiments were conducted using protocols approved by the Institutional 
Animal Care and Use Committee. 
 
Extraction and Sample Preparation for Mass Spectrometry 
S. marcescens UMH9 WT and mutant constructs were cultured overnight in LB with the 
appropriate antibiotics. The following day, cultures were centrifuged and pellets were washed 
twice in M9 minimal medium. Cultures were diluted 1:100 into M9 minimal medium with and 
without supplemented FeSO4 (36 µM) and then cultured overnight. Bacterial pellets and 
supernatants were collected by centrifugation (5,000x g, 7 minutes, 4°C) the next day, then 
delivered to the University of Michigan Natural Products Discovery Core. Detailed methods 
outlining the mass spectrometry protocol and analysis can be found in Appendix A.  
   
Detection of Siderophore Production 
Bacteria were cultured overnight in LB medium with aeration at 37˚C, and harvested by 
centrifugation the next day. Bacterial pellets were washed twice with M9 minimal medium and 
then diluted 1:100 into M9 minimal medium for overnight cultures with and without 36 µM 
FeSO4. The following day, cultures were adjusted to OD600 = 1.5 and then centrifuged (5,000x g, 
7 minutes, 4°C). Supernatants were removed. 100 µL of chrome azurol S (CAS) shuttle solution 
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was added to 100 µL of siderophore-containing supernatant [141]. 10 µM EDTA was used as a 
positive control. The CAS-supernatant mixture was allowed to develop for 20 minutes at room 
temperature. A visible color change from blue to red indicates siderophore production. This color 
change was measured using a MicroQuant spectrophotometer (Bio-Tek) at an absorbance of 630 
nm. Samples were measured in biological and technical triplicates. Final absorbance was 
calculated by dividing the average absorbance of triplicate samples by the absorbance of the M9 
solution alone. Error bars were calculated as the standard error of the mean. Statistical 
significance was determined using an unpaired t-test in Prism v.14.     
 
Data Availability 
All RNA-seq data in this publication have been deposited in NCBI’s Gene Expression 













Characterizing the Serratia marcescens Heme Acquisition Systems in the 
Context of Heme Toxicity and Pathogenesis 
 
Notes. Special thank you to the Snitkin Lab, especially Stephanie Thiede, who assisted with 
genome assembly and sequence variance analysis performed in this chapter.  
 
Heme and hemin are used interchangeably throughout this chapter.   
 
Abstract.  
In addition to siderophore systems scavenging iron, Gram-negative bacteria acquire iron from 
host heme using dedicated heme uptake systems. Typically, bacteria either encode a dedicated 
outer membrane transporter to uptake heme or a hemophore, a siderophore like molecule that is 
secreted from the bacterium and binds heme extracellularly, along with its own dedicated 
transporter. Interestingly, S. marcescens encodes both an independent receptor, and a hemophore 
system, called hem and has, respectively, to optimize its ability to uptake iron from heme. These 
systems have been described previously; however, they have not been examined in the context of 
mammalian infection. I began this study by mutating each heme system individually and then in 
conjunction in a double mutant in UMH9 to investigate heme acquisition as a fitness factor for 
Sm in the mammalian host. When these mutants were grown in culture conditions supplemented 
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with heme, the hem single mutant and hem/has double mutant exhibited normal growth, while 
the WT and has mutant exhibited an abnormally long lag phase before all strains reached a 
similar saturation. These end point cultures were reinoculated into new hemin conditions and the 
WT and Δhas mutant lag was resolved, but was recapitulated after routine culturing. Sequencing 
revealed mutations in a heme biosynthesis gene as well as in an iron storage locus in the WT and 
Δhas mutant, potentially explaining these in vitro growth phenotypes. To investigate how the 
hem and has systems contribute to in vivo pathogenesis, independent and mixed infections were 
performed in the bacteremia mouse model with the Δhem/has double mutant and WT. However, 
the Δhem/has double mutant did not display significant attenuation or fitness defect during 
infection, suggesting that heme uptake may not significantly contribute to Sm virulence in 




Access to iron is a growth limiting step for almost all bacterial pathogens and because of 
the crucial importance of iron, bacteria have capitalized on obtaining it from nearly all sources 
found in the human host. In previous chapters, I focused on iron acquisition from host proteins 
such as ferritin, transferrin, and lactoferrin via siderophores, small iron chelating molecules 
synthesized by the bacterium with a greater affinity for iron than these host proteins. This chapter 
focuses on obtaining iron bound to heme molecules within hemoglobin or hemopexin proteins 
that are abundant within the mammalian host [4].  
To acquire iron from heme, bacteria have evolved systems to strip the heme-bound iron 
found in hemoglobin, hemopexin, and myoglobin. These proteins contain up to four heme 
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molecules and constitute a major source of iron for pathogens. Typically, Gram-negative 
pathogens utilize either a hemophore or a dedicated heme receptor, and often employ hemolysins 
to acquire heme from red blood cells. These hemolysins disrupt the RBC membrane, liberating 
massive amounts of hemoglobin, which then initiates heme acquisition. The extensive machinery 
bacteria have developed to acquire iron from heme highlights the importance of these systems 
despite the presence of other iron acquisition systems, such as siderophores. Additionally, over 
30 heme receptors have been described in Gram-negative microbes, and some bacteria, such as 
Haemophilus sp., require exogenous heme to grow at all, further hinting at the importance of 
heme as an iron source [149-151]. 
Similar to toxic iron levels, uncontrolled heme import and inefficient heme degradation 
once inside the cell can result in detrimental toxicity to the bacterium [152]. “Free” heme 
interacts with membranes potentiating toxicity; therefore, organisms must have strategies to 
resist these toxic effects. Gram-negatives tend to be inherently resistant to heme toxicity because 
of their double membrane. In E. coli, a protein called HemS alleviates heme toxicity, and in 
Yersinia enterocolitica, HemS is essential for heme to be used as an iron source [38, 153]. 
Two heme uptake systems have been described in isolates of S. marcescens, called hem 
and has. The hem system consists of an outer-membrane, TonB-dependent receptor that is able to 
directly transport heme [101]. A previous study examined the mechanism of heme import by the 
has system by reconstituting the has locus into an E. coli mutant devoid of heme biosynthesis. 
They found that the has system encodes a secreted hemophore, HasA, that scavenges iron bound 
to heme. HasA then interacts with HasR, a membrane receptor, to handoff the scavenged heme 
and import it into the bacterium [103, 154, 155]. The has system is versatile in that it can acquire 
heme from a variety of heme sources, including hemopexin [156, 157]. The same is not true for 
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hem, making it more restricted in that it only takes up heme itself. Interestingly, the hem and has 
systems are differentially regulated depending on the external heme concentration. The hem 
system is preferred at heme concentrations above 10-6 M while the has system functions at 
concentrations of 10-8 M. Because hem and has do not function redundantly, S. marcescens 
theoretically is more plastic compared to other Gram-negatives in its heme uptake and has a 
larger pool of what iron it has access to. S. marcescens also utilizes a hemolysin, ShlA, to aid in 
iron-heme uptake by lysing red blood cells. Similar to E. coli and Y. enetocolitica, HemS is also 
found in the S. marcescens hem operon, but its function in heme degradation or utilization has 
not been determined.   
Currently, the role of heme acquisition during Serratia marcescens infection is unknown. 
My previous studies of S. marcescens iron acquisition via siderophores suggests that heme is the 
preferred iron acquisition system in specific organ sites (Chapter IV). Deletion of the 
serratiochelin locus reduced pathogenesis in the murine kidney and spleen but not the liver, 
whereas the cbs locus was dispensable in all organ sites examined. Moreover, a cbs/sch double 
knockout was less fit than the WT UMH9, but was still able to colonize the murine kidney, 
spleen, and liver [17]. This indicates that bacteria can persist without replication or that iron 
acquisition during infection is still possible through a non-siderophore system, such as heme. 
The importance of heme acquisition during pathogenesis has been established for some 
pathogens. For example, in E. coli, a deletion mutant knocking out both hma and chuA heme 
uptake systems had a fitness defect when competed against other iron acquisition uptake mutants 
in a mouse model of UTI [19]. I hypothesize that heme uptake is a preferred iron acquisition 
system and accounts for bacterial growth even when siderophores are absent.  
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In this chapter, the hem and has heme uptake systems of S. marcescens UMH9 are 
examined. Mutants were constructed that deleted the full hem and has loci individually (Δhem 
and Δhas) and together in a double mutant (Δhem/has). When grown in hemin conditions, the 
WT and Δhas mutant experienced a notably longer lag phase than the Δhem and Δhem/has 
mutants that was resolved upon direct re-exposure to heme. However, when strains were re-
cultured without heme, then exposed to heme again, the WT and Δhas mutant lag was 
recapitulated. Sequencing revealed potential mutations in heme biosynthesis and iron storage that 
may contribute to heme detoxification. Further, upon inoculation of the Δhem/has double mutant 
into the mouse bacteremia model, no defect in fitness or virulence was observed. These results 
together suggest a new understanding of the heme uptake systems in the context of heme toxicity 





The Δhas mutant and WT displayed lagging growth in hemin culture conditions.  
In order to determine how the heme acquisition systems contribute to the ability of Sm to import 
iron from heme, I individually deleted the hem and has systems in the UMH9 background as 
well as created a double mutant abrogating the function of both systems. I grew wild type UMH9 
and the mutants in iron-deplete M9 minimal medium supplemented with varying concentrations 
of hemin (0 µM, 10 µM, 30 µM, 50 µM, and 75 µM). At all tested hemin concentrations, the 
Δhem mutant and Δhem/has double mutant had a short lag phase, followed by exponential 
growth until saturation was reached at an OD600 of ~0.8 after 10 to 15 hours. Interestingly, the 
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WT strain and Δhas mutant consistently had a notably longer lag phase, wherein exponential 
growth began after 10 to 15 hours (Figure 5.1A-D). These mutants reached a similar saturation 
point as the Δhem and Δhem/has mutants; however, saturation was not reached until almost 20 
hours. This lag was reproducible at many hemin concentrations including nanomolar 
concentrations as low as 500 nM (Figure 5.2) and was exclusive to hemin conditions. When 
mutants were grown without hemin, all mutants grew comparably (Figure 5.1E). A similar trend 
was seen when iron was removed from the medium using Chelex-100 and added back at 36 µM 








Figure 5.1. The WT and Δhas mutant exhibited a notably longer lag phase compared to the 
Δhem and Δhem/has mutants when grown in hemin. 



















































































S. marcescens UMH9 wild type, the Δhem locus mutant, the Δhas locus mutant, and the 
Δhem/has double loci mutant were inoculated into chelexed M9 minimal medium containing 10 
µM (A), 30 µM (B), 50 µM (C), 75 µM (D), 0 µM (E) hemin and 36 µM FeSO4 (F) after 
overnight culture in M9 minimal medium. Cultures were incubated with aeration at 37 °C and 





















Figure 5.2. The WT and Δhas mutant have slower growth even at nanomolar hemin 
concentrations. 
S. marcescens UMH9 wild type, the Δhem locus mutant, the Δhas locus mutant, and the 
Δhem/has double loci mutant were inoculated into chelexed M9 minimal medium containing 100 
nM (A) or 500 nM (B) hemin after overnight culture in M9 minimal medium. Cultures were 
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The Δhas mutant and WT lag was lost when end-point cultures from hemin conditions 
were re-inoculated.  
The Δhas mutant and WT had an extended lag phase when grown in hemin conditions; however, 
they did eventually reach a comparable stationary phase to what was observed with the Δhem and 
Δhem/has mutants, suggesting that a potential suppressor mutation occurred during growth. To 
further explore this possibility, the heme system mutants and wild type were grown in differing 
hemin concentration as above. Then, end point primary cultures were re-inoculated into fresh 
iron-depleted media containing matching hemin conditions to determine if the extended lag 
phase was still observed. After the end-point cultures were re-inoculated into hemin conditions, 
the Δhas mutant and wild type no longer displayed a delayed lag phase and had exponential 
growth comparable to what was seen with the Δhem and Δhem/has mutants (Figure 5.3). Because 
the extended lag resolved after initial incubation in hemin conditions, this suggested the presence 
of a potential suppressor mutation that allowed the Δhas mutant and WT to have normal 
growth.          
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Figure 5.3. The WT and Δhas mutant lag were resolved after cultures exposed to hemin 
overnight were directly reinoculated into hemin conditions. 
All bacterial strains were grown overnight in either 10 µM (A), 30 µM (B), 50 µM (C), or 75 µM 
(D) hemin. The following day, these cultures were reinoculated into a new growth plate with 
matching hemin conditions. Bacterial growth was measured every 15 minutes at an optical 
density of 600 nm for both the initial hemin incubation (first column) and the endpoint 
reinoculation (second column). Grey arrows indicate the end-point cultures that were used as the 

















When end-point cultures were passaged and re-cultured, the Δhas mutant and WT lag was 
recapitulated.  
Upon direct re-inoculation of end-point cultures into a new growth plate, the extended lag 
seen in the has mutant and wild type growth was resolved. To confirm that this result was due to 
a suppressor mutation, I took end-point cultures after a lag was seen but when cultures reached 
stationary phase levels comparable to the hem and hem/has mutants, and struck them onto LB 
plates. Colonies were picked and grown in LB the following day. These cultures were then 
cultured in M9 minimal medium as they were when inoculated into the initial growth plate. I 
hypothesized that if the observed lag was due to a suppressor mutation, passaging and re-
culturing of the strains should not affect disappearance of the extended lag phase. However, 
when the Δhas mutant and WT were once again exposed to hemin, the prolonged lag phase was 
seen again, suggesting that a suppressor mutation did not occur (Figure 5.4). Rather, because the 
lag resolved when strains were directly transferred into hemin, but was seen again after re-
culturing, this potentially suggests phase variation from an invertible element, or the result of 
polynucleotide tracts, which are transient genetic variations usually in promoter regions that 











Figure 5.4. The WT and Δhas mutant lag is recapitulated after hemin end-point cultures 
are passaged before secondary hemin exposure. 
The WT, Δhem mutant, Δhas mutant, and Δhem/has mutant were initially exposed to heme and 
then end-point cultures were directly reinoculated into heme-matched conditions. These end-
point cultures were streaked onto plates, and re-cultured overnight in M9 minimal medium 
without hemin. The following day, cultures were inoculated into a new growth plate containing 





















































the indicated heme concentrations [50 µM (A) or 75 µM (B)], and OD600 measurements were 
taken every 15 minutes to examine bacterial growth. 
 
Mutations in heme biosynthesis and iron storage may account for the observed WT and 
Δhas mutant growth phenotypes 
To test the possibility that an invertible element or polynucleotide tract is responsible for 
these growth phenotypes, DNA sequencing was performed. The Δhem, Δhas, Δhem/has, and WT 
were exposed to heme in a bacterial growth plate. Once all strains reached similar saturation but 
after Δhas and WT lag was observed, DNA from these endpoint cultures was extracted, as a 
genetic element potentially resolving the lag would still be present in the genome. These cultures 
were also streaked onto LB and re-cultured without hemin so that the Δhas and WT lag would 
once again be observed if exposed to hemin, like previously shown after passaging (Figure 5.4). 
Because the lag is recapitulated after re-culturing (Figure 5.4) but not when directly re-exposed 
to heme (Figure 5.3), the potential genetic element that is present after heme exposure is no 
longer there. Therefore, DNA was extracted from these samples before second exposure to heme 
to compare to the early samples after initial heme exposure.    
Whole genome sequencing was completed and variation analysis between sequences 
from samples after initial and before second heme exposure was performed. Analysis revealed a 
potential intergenic modifier upstream of hemG as well as an insertion upstream of a 
bacterioferritin-associated ferredoxin gene in the WT and Δhas mutant after initial exposure to 
heme that may account for the observed phenotypes (Table 5.3). 
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Table 5.1. Genomic variants found in WT and the Δhas mutant after initial heme exposure 
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aAfter initial heme exposure = DNA was extracted immediately after overnight culture with 
heme. After re-culturing = DNA was extracted from strains that were exposed to heme overnight, 












Heme uptake does not appear to contribute significantly to in vivo pathogenesis 
Next, I wanted to determine if these in vitro phenotypes translated to the mouse 
bacteremia model. Although the Δhem/has double mutant performs better in excess heme than 
the WT does in vitro, I hypothesized that losing both heme systems in vivo would be detrimental. 
Mice were co-challenged with a 1-to-1 inoculum of WT and the Δhem/has mutant. After 24 
hours, spleen and liver were collected, and competitive indices were calculated. The Δhem/has 
mutant had a slight fitness defect although it was not statistically significant (Figure 5.5A).  
 The WT and Δhem/has mutant were also challenged independently in the mouse model 
for 24 hours, and bacterial burden was determined in the spleen and liver. Interestingly, there 
was only a small decrease in recovered bacteria from mice infected with the Δhem/has mutant 
when compared to WT bacteria that were recovered, suggesting that the heme uptake systems 







Figure 5.5. The Δhem/has double mutant is not attenuated and does not have a fitness 
defect in vivo. 
(A) CBA/J mice were infected with 5 × 107 CFU/mouse in a 1:1 mixture of the wild type and the 
Dhem/has double mutant via the tail vein. Mice were euthanized at 24 hours and the spleen and 
liver were collected from each mouse. Organs were homogenized. Homogenates were diluted 
and selectively plated. The relative fitness for the mutant was compared to that of the wild type 
and calculated as a competitive index (CI). The solid black line represents a CI of 1.0, meaning 
that the two strains competed equally. Solid grey lines represent median CI. Statistics were 




































































independently inoculated with either WT or Dhem/has mutant via the tail vein. Mice were 
euthanized 24 h post inoculation. Spleens (B), and livers (C) were collected and homogenized. 
Homogenates were diluted and plated. The dotted line indicates the limit of detection. 

















Experiments presented in this chapter examined the heme acquisition systems, hem and 
has, of S. marcescens UMH9, and revealed new insights into potential heme detoxification 
mechanisms by which heme is tolerated. Unlike other studies in Gram-negative bacteria, the 
results presented here suggest that heme uptake systems may not be critical to Sm bloodstream 
infection but do raise new questions around the utilization of heme in UMH9. 
Interestingly, the WT and Δhas mutant strains showed severely longer lag phases than the 
Δhem and Δhem/has mutants when exposed to heme in vitro. Heme toxicity may account for this 
longer lag that is associated with the hem system since this phenotype was only seen in strains 
that had an intact hem locus. The mutants lacking the hem locus, Δhem and Δhem/has, grew 
normally. However, all strains reached a similar saturation point by 24 hours which suggested a 
suppressor mutation in the WT and Δhas mutant that allowed them to begin exponential growth.  
Sequencing revealed two variances in the WT and Δhas mutant that may explain the 
observed growth phenotypes. The first was a mutation in hemG, a protoporphyrinogen IX 
oxidase involved in bacterial heme biosynthesis. Sm encodes all the required genes to synthesize 
heme intracellularly so if the WT and Δhas mutant are experiencing heme toxicity, a mutation 
stopping endogenous heme production could alleviate intracellular heme levels [158]. The 
second mutation was in bacterioferritin-associated ferredoxin, a gene hypothesized to encode a 
protein (ferredoxin) that liberates iron from an iron storage protein (bacterioferritin). 
Bacterioferritins possess four intrinsic heme groups that are deeply buried within the protein. 
Freeing of the iron bound to this heme requires the electron transferring capabilities of ferredoxin 
[159-161]. Therefore, a mutation in bacterioferritin-associated ferredoxin would inhibit iron 
liberation from heme molecules bound within bacterioferritin and limit intracellular levels of 
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iron. This would be particularly beneficial during heme detoxification and may be another 
explanation of the growth-phenotypes seen in the WT and Δhas mutant.   
These mutations may enable the WT and Δhas mutant to reach a similar saturation point 
as the Δhem and Δhem.has; however, it is still unknown why this growth phenotype is only 
observed in the WT and Δhas mutant, strains with intact hem. The sequencing analysis did not 
reveal an association between the hem locus and the growth lag. To speculate, the hem system is 
more active when extracellular heme concentrations are higher, above 10-6M, similar to the in 
vitro conditions tested here. The WT and Δhas mutant with functional hem systems are 
potentially experiencing such a high influx of heme through the hem system that it manages 
toxicity by transient mutation of heme biosynthesis and iron storage.   
Additionally, it is possible that differential regulation is contributing to the growth 
phenotypes. Because the long lag is recapitulated after re-culturing without heme, this could 
suggest recalibration of regulatory networks or time needed to synthesize metabolic precursors. 
RNA-sequencing would address this hypothesis examining gene expression of the WT and Δhas 
mutant as compared to the Δhem and Δhem/has mutants during the exponential growth phase.   
The in vitro growth conditions tested here are in the micro-molar range which is a large 
amount of heme. With these high heme conditions, it may not be surprising that potential heme 
toxicity is occurring, although it is interesting that this toxicity is occurring only in mutants with 
an intact hem locus. This leads to an important question around physiological concentrations of 
heme and if Sm would ever encounter such high levels. This is also particularly interesting since 
the WT experienced the hypothesized toxicity. Free heme concentrations within erythrocytes 
have been reported to be as high as 21 ± 2 µM [162]; therefore, these in vitro heme conditions 
could be encountered in vivo when RBCs are lysed.  
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Even with previous studies in other bacterial pathogens suggesting the importance of 
heme uptake in vivo, the double Δhem/has mutant did not show attenuation or a fitness defect in 
the mouse bacteremia model. This is perplexing since results in Chapter IV suggest that 
siderophores are not the sole source of iron uptake in the bloodstream, and heme uptake most 
likely was playing a role. The mutation found in hemG, a heme biosynthesis gene. This suggests 
that heme biosynthesis is utilized by Sm, suggesting that Sm prefers heme biosynthesis versus 
uptake, which would explain why there was no phenotype of the double heme mutant in vivo. 
Future research to evaluate this possibility is necessary.  
In summary, this chapter proposed interesting insights into heme toxicity related to the 
hem uptake system in UMH9 and hypothesized mechanisms of how this toxicity is overcome 
based on genomic analysis. While many questions remain regarding the physiological relevance 
of these findings, it prompts questions around how Sm persists in vivo if faced with high heme 
concentrations. Additionally, even though mouse studies did not reveal a crucial need for heme 
uptake via the hem and has systems, this may suggest alternative heme acquisition and 
metabolism strategies used by S. marcescens. 
 
Methods and Materials 
 
Bacterial Strains and Culture Conditions 
All Serratia marcescens strains used in this study are described in Table 5.1. Luria broth (10 g/L 
tryptone, 5 g/L yeast extract, 0.5 g/L NaCl) was used for routine culture of bacteria. Antibiotics 
were added to cultures at the following concentrations when appropriate: kanamycin (25 µg/ml), 
chloramphenicol (30 µg/ml), spectinomycin (100 µg/ml). M9 defined medium (0.1 mM CaCl2, 
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1mM MgSO4, 0.4% glucose) was also used to culture bacteria. Where specified, M9 was treated 
with Chelex-100 to remove iron, creating iron-limited conditions. Hemin (Sigma-Aldrich) was 
added to M9 cultures at the stated concentrations. FeSO4 (36 µM) was added back to M9 cultures 
where indicated.      
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Table 5.2. S. marcescens strains and plasmids. 
Name Relevant 
genotype 




   
UMH9 Wild type Bloodstream infection isolate [98] 
Δhem hem::kan 
 
Deletion of genes 07350 to 07380, hem, 





Deletion of genes 01515 to 01540, has, 






Double mutant with both gene, hem and 
has, deletions replaced with the indicated 
antibiotic cassette.  
This study 
Plasmids    
pKD4  Source of kanamycin resistance gene [139] 
pKD3  Source of chloramphenicol resistance gene [139] 














Construction of UMH9 Heme Mutants 
The lambda red recombinase system was used to make single and double mutations in the hem 
and has operons [139]. Using pKD4 and pKD3, the kanamycin and chloramphenicol resistance 
cassettes, respectively, were PCR amplified using primers with `50 bp homology to the 5’ end of 
the gene locus and ~20 bp of homology to the pKD3/4 3’ end of the primer. Primers used are 
listed in Table 5.2. PCR products were digested with DpnI and electroporated into UMH9 cells 
harboring pSIM19 after heat treatment for 20 minutes at 42 °C. pSIM19 was removed from the 
















Table 5.3. Primers for mutant constructiona 













aPrimer sequences are listed 5’ to 3’. Underlined sequences in mutant construction primers are 


















Growth of S. marcescens Strains 
Bacterial strains were cultured with aeration overnight in LB medium at 37 ˚C. The following 
day, bacteria were collected by centrifugation and washed twice with M9 minimal medium. 
Bacteria were suspended in M9 minimal medium and 30 µL were used to inoculate 3mL of 
chelexed M9 minimal medium for overnight cultures. A sample of culture (3 µL) was used to 
inoculate each well of a 100-well growth plate containing 300 µL of chelexed M9 with the 
indicated hemin concentration to an OD600 of 0.01. Control conditions were also included 
measuring growth in iron depleted M9 minimal medium and M9 minimal medium with 36 µM 
FeSO4 added back. After initial growth in hemin, endpoint cultures were taken and re-inoculated 
into a new growth plate with identical hemin conditions. These cultures were also struck onto 
antibiotic LB plates, recultured overnight in LB, washed with M9 minimal medium, recultured 
overnight in M9 minimal medium, then inoculated into another hemin growth plate. Growth 
curves were performed to observe extended lag phase for particular mutants, resolution of this 
lag upon direct endpoint reinoculation into heme, and then recapitulated lag after reculturing. 
Growth curves were performed in biological and technical triplicates. Plates were incubated at 
37˚C with continuous shaking and OD600 was measured every 15 minutes for 21 hours using a 
BioScreenC plate reader. 
 
DNA Purification and Sequencing 
DNA was extracted from Δhem, Δhas, Δhem/has, and WT cultures after initial growth in hemin 
conditions, and then after re-culturing in LB and M9 minimal medium but before second 
exposure to hemin. DNA purification was performed using the Gram-negative extraction 
protocol of the Qiagen Blood and Tissue Kit. Cellular lysis was performed using Proteinase K 
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and DNA was eluted in Qiagen EB buffer. DNA samples were library-prepped and sequenced by 
the University of Michigan Advanced Genomics Core. A NovaSeq (S4) 300 cycle was used for 
sample sequencing, providing an expected 10 million reads per sample with more than 100 X 
sequence coverage.  
 
Genome Assembly and Variance Analysis 
After sequencing, PATRIC’s online assembly and variance analysis platforms were used to 
assemble genomes and identify mutations and genetic variation between particular samples. 
Parameters for variance analysis consisted of alignment using Bowtie2 and SNP caller, 
FreeBayes. Variance between samples after initial heme exposure and before second heme 
exposure after re-culturing without heme were compared. Variances that were found in all 
mutants were filtered out. Unique mutations found in both the WT and Δhas mutant analysis 
were identified.  
 
Murine Model of Bacteremia 
Overnight cultures of WT and Δhem/has were harvested by centrifugation (3500x g for 30 
minutes at 4 ˚C) and resuspended in phosphate-buffered saline (PBS) to a density of 5 x 108 
CFU/ml. Two groups of five female CBA/J mice (Jackson 000656) aged 6-8 weeks were 
independently inoculated with either UMH9 WT or the Δhem/has double mutant. An inoculum 
(100 µL) of 5 x 108 CFU/ml was injected into the tail vein. Infection was allowed to progress for 
24 hours. Spleen, and liver were collected and homogenized in PBS. Homogenates were diluted 
and plated onto LB agar or LB agar containing the appropriate antibiotics using an Autoplate 
4000 spiral plater (Spiral Biotech) and incubated overnight at 37˚C. Bacterial colonies were 
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counted the following day using a QCount (Chemopharm). For co-challenge experiments, the 
following modifications were made. The Δhem/has mutant strain was combined in a 1:1 mixture 
with the UMH9 WT strain at 5 x 108 CFU/ml. Competitive indices were calculated using the 










Conclusion and Final Thoughts
 
Summary of Findings 
With the emergence of Sm as a pathogen of significant clinical relevance, there is an 
express need to understand the underpinnings of Sm pathogenesis. Correspondingly, there has 
been an increase in research to understand Sm infection. While studies have identified relevant 
virulence factors and provided foundational work to understanding Sm, they have not truly 
defined Sm pathogenesis in the context of mammalian infection. This work is critically important 
to ultimately controlling these infections. The work presented in this dissertation aimed to 
address this gap specifically pertaining to Sm virulence factors involved in iron acquisition. In 
the pursuit to ascertain this knowledge, I discovered that iron acquisition in Sm is much more 
intricate than what was originally hypothesized and unexpected, yet interesting insights 
ultimately emerged, providing a deeper appreciation for a previously underestimated 
pathogen.       
In Chapter II, RNA-sequencing identified all genes involved in iron acquisition in the 
clinical bloodstream isolate UMH9. This included siderophore biosynthetic loci, heme uptake 
systems, ferrous iron, and citrate uptake, as well as orphan iron receptors regulated by iron 
concentration. The results of this Chapter guided the selection of iron acquisition systems to be 
studied further in the proceeding Chapters.   
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In Chapter III, the siderophore biosynthetic gene clusters that were identified by RNA-
seq in Chapter II were explored. These gene clusters were called cbs and sch, respectively due to 
similarities of the UMH9 clusters to previously identified chrysobactin and serratiochelin loci. 
The absence of two NRPS genes, one from each locus, in a double mutant which deleted 
presumed essential siderophore biosynthetic machinery, resulted in severely defective growth in 
iron-limited conditions. Interestingly, this mutant had notably increased siderophore production 
quantified by the CAS assay, and the presence of serratiochelin in mutant supernatants was 
confirmed by mass spectrometry. This suggested that despite the ability to produce a 
siderophore, the double NRPS mutant could not take up the bound iron, resulting in defective 
growth under iron-limitation. Intriguingly, when the NRPS genes were deleted individually in 
single mutants, they performed comparably to wild type UMH9 in all assays. The single mutants 
grew to WT levels in iron-depletion, and showed similar iron chelation levels.  
These results are surprising because they suggest that NRPS genes, typically exclusively 
involved in siderophore biosynthesis, are potentially involved in siderophore transport, and they 
also suggest that these NRPSs have redundant functions in transport since the single mutants 
performed to WT levels, and the double mutant displayed the phenotype. This supports the 
possibility that the siderophore loci in Sm have the ability to crosstalk and support each other via 
redundancy. How these two NRPSs contribute to transport and iron uptake is currently unknown. 
Previous work has shown NRPSs to associate with bacterial membranes; therefore, they may 
interact with receptors or permeases during siderophore transport to facilitate necessary 
conformational changes that occur during ferri-siderophore uptake. These results challenge the 
traditional understanding of NRPSs and the role they play in iron acquisition.    
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In Chapter IV, to definitively determine the contribution of the siderophore loci, cbs and 
sch, to mammalian bloodstream infection, full siderophore locus mutants were constructed, in 
both single and double mutant combinations. Only mutants lacking the sch operon (sch and 
cbs/sch), and thus lacking serratiochelin, showed defective iron chelation, displayed inhibited 
growth in iron-poor conditions, and were attenuated in the mouse bacteremia model. All of these 
results taken together suggested that serratiochelin was necessary for full virulence during 
bloodstream infection; however, the cbs locus was dispensable and played little to no role during 
in vitro iron chelation or in vivo infection. 
In other Gram-negative bacteria, such as E. coli and K. pneumoniae, siderophores have 
redundant, and sometimes hierarchical, roles, but it’s uncommon to observe a siderophore with 
no contribution to infection such as what was seen with chrysobactin in Chapter IV. Because Sm 
is an environmental pathogen, chrysobactin may contribute to plant or insect pathogenesis or 
even scavenging iron from soil, but it may not have the iron affinity to effectively compete with 
host proteins in the context of human infection.    
Chapters III and IV demonstrate that siderophore biosynthesis and transport is 
significantly more complicated than what was initially expected and does not follow the 
canonical understanding of iron acquisition in Gram-negative bacteria. While serratiochelin 
plays a significant role in bacteremia, the role of chrysobactin is currently unknown. However, 
given the results of Chapter III, it is possible that chrysobactin itself does not significantly 
contribute, but the NRPS, cbsF, within its locus may play a role in transport, and thus, is why the 
cbs gene cluster is conserved. It is also worth considering the amount of selective pressure on the 
cbs locus for Sm as a mammalian pathogen versus in its other niches. Additionally, the schF0 
NRPS gene in the serratiochelin locus is completely bypassed in the biosynthesis of 
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serratiochelin; therefore, much like cbsF, it could be conserved due to a potential role in 
transport.  
Chapter V aimed to elucidate the role of heme uptake during bacteremic infection. While 
the Δhem/has mutant did not show virulence attenuation or a fitness defect in the mouse 
bacteremia model, some interesting hypotheses on heme detoxification mechanisms were 
proposed based on results from in vitro growth in hemin. Upon mutant exposure to heme, a 
lagging growth phenotype was observed in mutants that had functional hem systems, WT and 
Δhas. Sequencing revealed potential mutations in heme biosynthesis and iron storage that would 
lower the intracellular heme levels, suggesting novel mechanisms by which heme is tolerated. 
The relevance of these findings to in vivo pathogenesis is still to be determined; however, the 
results of this chapter provide new insights into the functionality of the hem and has heme uptake 
systems 
This work provides insight into the complexity of Sm iron uptake and identified potential 
non-canonical functions of both siderophore and heme acquisition systems. Collectively, these 
studies contribute to the growing body of work aimed at understanding not just the virulence of 
Serratia marcescens but also other pathogens that are emerging from seemingly harmless 
origins. Because Sm has unique nuances to its pathogenesis, it’s likely that other pathogens do as 
well. This may ultimately require a new perspective on how these infections are treated and 
novel approaches to drug development.  
 
Future Directions 
The work presented here leads to several open questions, both in the context of my results 
and more broadly in the field of Gram-negative pathogenesis. More research is required to fully 
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understand Sm iron acquisition. Future directions stemming from my work include: elucidating 
Sm siderophore transport, continuing to explore the role of heme acquisition in mammalian 
infection and the physiological relevance of heme toxicity, and coordination between all iron 
uptake systems. In a broader context, translatable studies examining iron acquisition systems as 
druggable targets should be explored. 
 
Next Steps for Siderophores in Pathogenesis Research 
Siderophore transport is generally understood from mechanistic studies in E. coli, which 
have been translated to iron uptake via siderophores in other Gram-negative bacteria [163, 164]. 
My work suggests that this model is not necessarily true for siderophore import in Sm. The 
implication of the results in Chapter III that particular NRPSs are involved in siderophore 
transport is novel, thus additional studies should be conducted to confirm this role. It is possible 
that the NRPSs have a role in siderophore degradation once inside the bacterium to release the 
iron instead of a direct impact on transport itself. Both hypotheses suggest a unique mechanism 
of NRPS functionality, and elicit follow up questions around this being a Sm specific feature or a 
more ubiquitous mechanism among environmental pathogens. Further, my results imply a 
redundancy in function between the NRPS genes potentially involved in siderophore uptake, that 
individually each can effectively perform. This may suggest regulatory crosstalk or indicates that 
baseline levels of the NRPS may be sufficient to compensate for the other. This could also 
elucidate the role of the cbs locus during infection since the actual chrysobactin molecule does 
not significantly contribute to pathogenesis. Whatever the role of the NRPS in siderophore 
uptake or iron utilization, it is clear that further exploration will yield interesting findings. 
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Additionally, Sm requires the siderophore serratiochelin to achieve full virulence during a 
mouse model of bacteremia [17]. Serratiochelin is an interesting molecule as its biosynthesis is 
an evolutionary combination of the enterobactin and vibriobactin synthesis pathways [108]. The 
mixing and matching of these siderophore loci to create serratiochelin suggests that Sm is an 
important intermediary for genetic transfer between different Enterobacterales. Horizontal 
genetic transfer drives the evolutionary dynamic of creating diverse genomes and has been 
documented extensively in the literature. For example, a study examining the repertoire of 
polysaccharides between 45 Enterobacteriaceae genera found high rates of genetic transfer of 
both whole loci and individual genes from multiple bacterial species to create high evolutionary 
diversity within polysaccharide loci [165]. Analogous genetic transfer is seen in the Sm 
serratiochelin locus; therefore, finding similar biosynthetic pathways among siderophore loci 
could provide fascinating insights into the evolution of small molecule biosynthesis.    
 
Next Steps for Heme Acquistion Research 
      Despite previous advances describing the mechanistic function of Sm heme uptake [37, 
40, 102, 130, 156], the heme acquisition systems of Sm have a yet to be determined role in 
pathogenesis, and in the broader context of iron acquisition itself. Even though my results 
suggested a minor role of heme uptake in bacteremia pathogenesis, a larger contribution of these 
systems could be found in other infection models such as urinary tract infections or wound 
infections. While the heme systems are complex on their own and should be understood 
individually, studying them alongside siderophores will add to our understanding of what iron 
uptake systems are necessary to colonize certain organs or are temporally required as infection 
progresses. Since both iron and heme are toxic at high levels and particular systems are likely 
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beneficial at differing organ sites, it is advantageous for a bacterium to coordinate all iron uptake 
systems. It is probable that exploring cross-talk between siderophores and heme uptake will 
reveal interesting regulatory pathways that promote the most advantageous iron system 
expression.   
Significant questions remain regarding how the ShlA hemolysin and heme uptake 
systems function in concert. It is assumed that ShlA releases heme from red blood cells which is 
then taken up by the heme systems; however, this relationship has not been empirically tested 
and also leads to questions around heme toxicity. If a deluge of heme is suddenly available to the 
bacterium, efficient degradation and storage systems must be employed to avoid toxicity. This 
makes the results of Chapter V even more interesting and physiologically relevant since the WT 
strain did have an extended lag phase in excess heme in vitro and may experience overwhelming 
levels of heme in vivo. It is currently unknown how toxic levels of heme kill bacteria. It is 
possible once heme is degraded, hydroxyl radicals accumulate from free iron and cause 
intracellular damage; however, studies speculate that toxicity is likely caused by DNA damage 
related to the heme itself [166, 167]. Bacteria do employ mechanisms of heme tolerance to avoid 
toxicity. These typically consist of actively effluxing heme, sequestering heme, or degrading it 
[168-172]. More work is needed to define Sm heme tolerance systems, but Sm does encode 
HemS, which has been identified and explored as a heme sequestration and degradation protein 
in E. coli, Y. enterocolitica, and Y. pestis, although its definitive function has not been described 
[173-175]. Additional research examining the functionality of Sm heme systems and how they 
contribute to heme tolerance is necessary to fully understand Sm heme uptake.    
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Serratia marcescens in polymicrobial infections 
Serratia marcescens is commonly isolated from polymicrobial infections; therefore, it 
would also be interesting to study Sm in a polymicrobial context [176]. Sm encodes several 
“orphan” iron receptors that do not have characterized substrates. It is possible that these are 
additional receptors for its own siderophores; however, it is also likely that these are able to 
import siderophores made by other microbes. Evaluating if these receptors contribute to Sm 
fitness in a polymicrobial setting would provide insight on opportunistic infections. Additionally, 
possession of a hemophore also seems like an advantage in a polymicrobial context since 
hemophores are not ubiquitous across bacterial species. Similarly, the siderophore serratiochelin 
has not been identified in other Gram-negative pathogens outside of the Serratia genus, whereas 
yersiniabactin and aerobactin are found across several. Having unique iron uptake systems that 
cannot be “hijacked” by surrounding microbes is beneficial in polymicrobial environments. 
Although, while not yet documented, other pathogens could encode serratiochelin receptors. 
Studying how various iron uptake systems play a role when iron is being competed for, not just 
with the host but with other pathogens, would provide insightful perspectives on how microbes 
interact and equip themselves with virulence factors that are advantageous against other 
bacteria.   
 
Drug Development Potential 
A comprehensive understanding of iron acquisition in Sm, as well as Enterobacterales, 
could contribute to vaccine or drug development inhibiting iron uptake. From a high-level 
perspective, antibiotics that target iron acquisition have therapeutic potential. With iron being a 
critical nutrient, blocking bacterial uptake is a novel approach to antibiotic development. 
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However, targeting iron acquisition is complicated due to the arsenal of redundant uptake 
systems most bacteria possess. Targeting one system does not necessarily inhibit all iron uptake. 
However, because most iron transporters, importing both siderophores and heme, are TonB 
dependent, a universal iron-targeting antibiotic approach would be to inhibit the TonB protein 
that is responsible for energy transduction needed for proper receptor functionality [177, 178]. 
Additionally, a therapy that binds consensus sequences of the ferric uptake regulator (Fur) could 
block transcription of all iron uptake genes, and starve the bacterium of iron. While iron uptake 
systems are numerous and redundant in most bacteria, making iron uptake a difficult antibiotic or 
vaccine target, a broader approach to encompass them all may prove effective not just in a single 
bacterial species but to many that use the same uptake and regulatory mechanisms. For example, 
gallium compounds can disrupt ferric iron-dependent metabolic pathways and have shown 
antimicrobial activity against multi-drug resistant bacterial species [179].   
A broad vaccine or antibiotic approach is beneficial to treat infections caused by many 
bacterial species or when pathogen identification cannot be done expediently. However, 
controlling Sm infections with a targeted therapeutic approach could be explored because of the 
uniqueness of the Sm iron acquisition systems. The advantage to identifying unique systems 
within a bacterial species is that these systems can be specifically targeted, leaving the host 
microbiome intact and avoiding unnecessary damage to the host. Antibiotics that target only 
particular pathogens also lessens the risk of antibiotic resistance developing among bacterial 
species. Therefore, identifying unique virulence factors or systems of pathogens could 




Sm has been recognized as a significant human pathogen for several decades yet we are 
only beginning to understand its pathogenesis. Its rapid emergence from environmental pathogen 
to concerning human infection is clinically alarming and basic research examining virulence and 
fitness factors is crucial to vaccine or drug development. While studying virulence in humans is 
critical to understanding pathogenesis, there is an entire subdivision of research studying Sm in 
an environmental capacity. Not merging these two fields of study, human and environmental 
pathogenesis, would be a missed opportunity in the field. Studying Sm from an environmental 
comparator perspective would elucidate how Sm quickly became pathogenic in humans. One 
study compared a clinical Sm strain to a Sm strain isolated from a fly, and found that the clinical 
isolate had notably more insertional sequence transposases and integrases, and multidrug 
transport systems. Differences in virulence factors such as fimbriae, O-antigen, and secretion 
systems were also described between the clinical and environmental Sm isolates [88]. 
Continuing to examine environmental strains of Sm versus clinical isolates could provide 
valuable insights into the evolution of its virulence.      
With antibiotic resistance to beta-lactams and polymyxins on the rise and outbreaks 
within hospitals becoming more frequent, Sm has the potential to pose a major threat to public 
health. Because Sm is a ubiquitous pathogen infecting plants, animals, humans, and residing in 
environmental reservoirs, this brings a broader, “One Health” perspective to studying Sm. By 
containing the environmental burden of Sm, this may limit infections and outbreaks in humans 
and contribute to balancing the other prongs of the One Health initiative that Sm affects. 
Ultimately, this research informs the broader field of bacterial pathogenesis and how the 
virulence of an emerging pathogen fits into this narrative. Following the evolution of Sm from an 
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environmental bacterium thought to be harmless in mammals to where it is today, an antibiotic 
resistant and clinically problematic pathogen, we can be more aware of pathogens following a 
similar trajectory before they become a public health threat. Taking insights gained from this 
work, applying them to other pathogens and how virulence factors translate to human disease is 
an initial approach.      
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Appendix A 
Supplemental Material for Chapters II-IV 
 
Table A.1. Up-regulated genes under iron limitation 
Gene Description Log2FC PValue 
BVG96_RS11640 Sigma-70 family RNA polymerase sigma factor 8.33 1.92E-06 
BVG96_RS07370 TonB-dependent hemin, ferrichrome receptor 7.77 4.92E-06 
BVG96_RS14180 S9 family peptidase 7.66 7.94E-06 
BVG96_RS21980 TonB-dependent receptor 7.62 6.94E-04 
BVG96_RS07375 Hemin uptake protein, HemP 7.47 3.42E-06 
BVG96_RS14185 Energy transducer, TonB 7.19 1.98E-05 
BVG96_RS12820 TonB-dependent receptor 7.02 1.78E-05 
BVG96_RS07365 Hemin transport protein, HmuS 6.88 5.83E-06 
BVG96_RS08810 Enterochelin esterase 6.85 9.28E-06 
BVG96_RS08805 MbtH family protein 6.74 7.28E-06 
BVG96_RS09295 Hypothetical protein 6.66 3.08E-05 
BVG96_RS21985 Condensation protein 6.65 5.03E-04 
BVG96_RS01530 Hemophore, HasA 6.64 1.72E-04 
BVG96_RS15325 Glutaredoxin-like protein, NrdH 6.54 2.55E-06 
BVG96_RS07355 Iron ABC transporter permease 6.53 3.77E-06 
BVG96_RS21990 Hypothetical protein 6.47 9.56E-04 
BVG96_RS14190 Uncharacterized iron-regulated protein 6.42 4.39E-06 
BVG96_RS08800 Non-ribosomal peptide synthetase 6.30 3.29E-05 
BVG96_RS08815 TonB-dependent siderophore receptor 6.27 2.53E-05 
BVG96_RS12825 Iron ABC transporter substrate-binding protein 6.26 3.33E-05 
BVG96_RS07360 Hemin ABC transporter substrate-binding protein, HemT 6.25 7.12E-06 
BVG96_RS11995 Hypothetical protein 6.21 4.41E-06 
BVG96_RS07980 sigma-70 family RNA polymerase sigma factor, FecI 6.15 1.14E-05 
BVG96_RS21975 Glutamate racemase 6.04 1.57E-04 
BVG96_RS07975 Fec operon regulator, FecR 6.02 6.31E-04 
BVG96_RS21970 Amino acid adenylation domain-containing  protein 5.95 2.87E-04 
BVG96_RS09295 Pyridoxamine 5'-phosphate oxidase 5.94 1.47E-04 
BVG96_RS01485 TonB-dependent siderophore receptor 5.87 4.36E-05 
BVG96_RS21965 Condensation protein 5.81 2.56E-04 
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BVG96_RS22005 MbtH family protein, chaperone 5.79 1.83E-05 
BVG96_RS11995 Hypothetical protein 5.76 5.54E-06 
BVG96_RS05215 Hypothetical protein 5.74 7.20E-05 
BVG96_RS14175 TonB-dependent receptor 5.73 2.17E-05 
BVG96_RS07350 Heme ABC transporter ATP-binding protein, HemV 5.70 7.36E-06 
BVG96_RS11635 Hypothetical protein 5.64 7.64E-06 
BVG96_RS22030 Isochorismatase 5.61 5.77E-05 
BVG96_RS22025 DHB adenylate synthase-AMP ligase 5.58 8.18E-05 
BVG96_RS22035 Hypothetical protein 5.54 1.17E-04 
BVG96_RS14005 TonB-dependent siderophore receptor 5.54 5.95E-05 
BVG96_RS22000 Enterochelin esterase 5.46 5.44E-05 
BVG96_RS22020 Isochorismate synthase 5.32 4.71E-05 
BVG96_RS01525 TonB-dependent receptor, HasR 5.25 7.58E-05 
BVG96_RS17205 Biopolymer transporter, ExbB 5.08 4.29E-05 
BVG96_RS14365 Hypothetical protein 5.03 1.54E-04 
BVG96_RS23465 Putative inner membrane protein, hypothetical 4.81 6.33E-05 
BVG96_RS01495 Shikimate kinase 4.72 6.57E-05 
BVG96_RS22010 Enterobactin synthase subunit F 4.60 2.59E-04 
BVG96_RS11645 TonB-dependent receptor 4.50 4.74E-05 
BVG96_RS21995 TonB-dependent siderophore receptor 4.41 5.26E-04 






























BVG96_RS12895 Cytochrome C -6.14 5.81E-05 
BVG96_RS10870 Nitrate reductase subunit alpha -5.95 1.23E-04 
BVG96_RS12900 Trimethylamine-N-oxide reductase, TorA -5.81 1.59E-05 
BVG96_RS10865 Nitrate reductase subunit beta -5.46 1.53E-04 
BVG96_RS10860 
Nitrate reductase molybdenum cofactor assembly 
chaperone -5.25 7.09E-05 
BVG96_RS12885 Hypothetical protein -5.02 5.37E-04 
BVG96_RS10935 NarK family nitrate/nitrite MFS transporter -5.01 2.37E-04 
BVG96_RS12880 
Bifunctional PTS fructose transporter subunit  IIA/HPr 
protein -4.84 6.02E-04 
BVG96_RS12875 1-phosphofructokinase -4.59 3.33E-04 
BVG96_RS22140 
Succinate dehydrogenase/fumarate reductase iron-sulfur 
subunit -4.55 1.65E-03 
BVG96_RS20690 Sugar kinase -4.45 1.01E-03 
BVG96_RS09970 Sugar ABC transporter ATP-binding protein -4.12 2.89E-04 
BVG96_RS09965 Xylulokinase -3.99 9.39E-04 
BVG96_RS13225 
2-succinyl-5-enolpyruvyl-6-hydroxy-3-  cyclohexene-1-
carboxylic-acid synthase -3.97 9.25E-05 
BVG96_RS06310 Non-heme ferritin -3.96 8.23E-04 
BVG96_RS00585 Histidine ammonia-lyase -3.95 1.51E-03 
BVG96_RS00290 3-isopropylmalate dehydratase small subunit -3.77 3.94E-04 
BVG96_RS13220 
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate 
synthase -3.74 1.22E-04 
BVG96_RS07905 Hypothetical protein -3.70 2.47E-04 
BVG96_RS20685 MFS transporter -3.65 1.86E-04 
BVG96_RS13355 Hypothetical protein -3.64 2.90E-04 
BVG96_RS12870 PTS fructose transporter subunit IIBC -3.64 2.19E-04 
BVG96_RS13350 Sugar phosphatase -3.59 8.90E-05 
BVG96_RS04485 Anaerobic C4-dicarboxylate transporter DcuC -3.58 4.54E-04 
BVG96_RS20025 phosphoglycerate mutase -3.52 5.59E-04 
BVG96_RS00580 Amino acid permease -3.52 1.64E-04 
BVG96_RS09690 Glycyl radical enzyme -3.43 1.11E-03 
BVG96_RS05830 Anaerobic C4-dicarboxylate transporter -3.35 6.30E-04 
BVG96_RS13210 o-succinylbenzoate synthase -3.35 1.63E-04 
BVG96_RS09975 ABC transporter permease -3.22 5.54E-04 
BVG96_RS13205 o-succinylbenzoate--CoA ligase -3.19 1.91E-04 
BVG96_RS13215 1,4-dihydroxy-2-naphthoyl-CoA synthase -3.11 1.04E-03 
BVG96_RS00160 Putative membrane protein -3.04 4.88E-04 
BVG96_RS22595 U32 family peptidase -3.00 5.51E-04 
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BVG96_RS17660 TIGR01212 family radical SAM protein -2.93 1.41E-03 
BVG96_RS12925 Mannonate dehydratase -2.88 4.10E-04 
BVG96_RS18275 Maltose operon protein MalM -2.88 7.01E-04 
BVG96_RS22725 L-asparaginase  -2.80 1.52E-03 
BVG96_RS10930 
Undecapreyl-phosphate alpha-N-acetylglucosaminyl 1-
phosphate transferase -2.71 6.42E-04 
BVG96_RS07530 Superoxide dismutase [Fe] -2.71 8.39E-04 
BVG96_RS00275 Transcriptional regulator, SgrR -2.55 1.12E-03 
BVG96_RS07910 MerR family transcriptional regulator -2.48 8.42E-04 
BVG96_RS10855 Respiratory nitrate reductase subunit gamma -2.45 1.02E-03 
BVG96_RS16055 Molecular chaperone -2.31 1.65E-03 



































Figure A.1. Detection of serratiochelin A by mass spectrometry. 
Spectra of serratiochelin A showed the presence of an [M+H]+ ion at 430.1723 m/z and an 






















Figure A.2. UMH9 growth under iron-limitation is dependent upon presence of the sch 
locus. 
S. marcescens UMH9 wild type, the cbs locus mutant (Δcbs), the sch locus mutant (Δsch), and 
the cbs/sch double loci mutant (Δcbs/sch) were inoculated into LB medium containing 250 µM 
(A) or 350 µM (B) dipyridyl after culture overnight in LB with 250 µM dipyridyl. Cultures were 
incubated with aeration at 37˚C and OD600 readings were taken every 15 minutes to measure 














































Supplemental dipyridyl growth curve
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Methods and Materials  
 
RNA-seq analysis. RNA-seq analysis was performed by the University of Michigan 
Bioinformatics Core. Adapter sequences and low-quality ends were trimmed off the reads using 
Trimmomatic v0.36 [180]. EDGE-pro was used to align reads to the UMH9 reference genome 
(NCBI Reference Sequence: NZ_CP018923.1) and quantify differential expression [181]. Gene-
level read count data were processed using the edgeR package in R for normalization and 
differential expression testing between the two groups [182]. By requiring a False Discovery 
Rate (FDR) ≤0.05 and Fold Change (FC) ≥1.5, differentially expressed genes were identified. 
 
Supernatant Preparation for Mass Spectrometry. The supernatants from cultured microbial 
cells were transferred into vials and dried using Biotage® V10 Touch. The extracts were then 
brought up in a 1:1 mixture of HPLC grade methanol and milliQ water to achieve a 
concentration of 1 mg/mL. Each sample was centrifuged for 5 min at full speed and supernatant 
was transferred to MS vials prior to analysis using UHPLC-MS/MS. 
 
Liquid Chromatography. Samples were analyzed using an Infinity II 1290 UHPLC from 
Agilent Technologies using Luna 5µ C18(2) 100 Å that was 50 mm in length and 1.0 mm in 
diameter. We used a flow rate of 0.3 mL/min at 25°C. The analytes were separated using a linear 
gradient with 0.1% formic acid in water (A) and in methanol (B); 0-1 minute at 30% B, followed 
by 6 minute gradient from 30-100% B, followed by 1 minute at 95% B and 1 minute of re-
equilibration at 30% B.  
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Mass Spectrometry. The eluent from LC was followed by electrospray ionization (Dual AJS 
ESI) in positive mode and MS/MS detection on a 6545 quadrupole-time-of-flight (qTOF) mass 
spectrometer (Agilent Technologies). The ESI source parameters were: end plate offset, 500 V; 
capillary voltage, 3500 V; nebulizer, 35 psi (nitrogen gas); dry gas, 11.0 L/min; sheath gas 
temperature of 350°C and dry temperature, 320°C. The ion optics settings included: Oct 1 RF 
amplitude, 750 Vpp; fragmentor 175 V; skimmer 65 V; in-source collision-induced dissociation 
(isCID) energy, 30.0 eV and isolation width of 1.3 amu; quadrupole low mass cut-off, 50.0 m/z. 
Data were acquired both for molecular ions (MS1) and fragment ions (MS2) in data-dependent 
fragmentation (auto MS/MS). For MS1 acquisition, three spectra were collected per second (3 
Hz).  
 
MZmine 2 Data Preprocessing Parameters. The .mzXML data for all the samples were 
created using MSConvert and the obtained data sets were processed using MZmine 2 version 
2.51 [183, 184]. The mass detection was realized using noise level at 10 complete data sets. The 
collected MS data point was connected to extracted ion chromatogram using the ADAP 
chromatogram builder with a minimum highest intensity of 2000, and an m/z tolerance of 10 ppm 
[185]. The isobaric peaks were de-convoluted using the chromatogram deconvolution feature of 
MZmine 2 with minimum peak height of 2000, baseline level of 1000, m/z range for MS2 scan 
pairing at 0.02 Da, and retention time (RT) range for MS2 scan pairing at 0.1 min. Isotopologues 
were grouped using the isotopic peak grouper algorithm with an m/z tolerance of 10 ppm and RT 
tolerance of 0.1 min. For the grouped data set, a peak alignment step was performed using the 
join aligner module [m/z tolerance of 0.004 (or 10 ppm), weight for m/z of 75, weight for RT of 
25, and absolute RT tolerance of 0.1 min].  
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Appendix B 
Insights into Citrate as a Chelator in the Absence of Serratiochelin
 
Summary 
Chapter IV elucidated how the sch locus is necessary for UMH9 to compete with 
exogenous chelators such as dipyridyl or to strip iron from host proteins in serum. Results also 
revealed the significant contribution serratiochelin plays during murine infection. However, 
growth experiments in iron-depleted M9 minimal medium did not recapitulate the growth defect 
when the sch locus was deleted analogous to what was observed in medium supplemented with 
dipyridyl (Figure B.1). I hypothesized that an exogenous chelator was needed in the medium to 
necessitate the use of a siderophore. However, this prompted the hypothesis that another iron 
uptake system was transporting sufficient iron in M9 minimal medium conditions even when 
siderophores were deleted. Therefore, qPCR was performed in the full siderophore locus mutants 
to evaluate the expression of the other iron uptake systems identified by RNA-seq in Chapter II, 
including: heme uptake systems (hem and has), ferrous iron uptake systems (efe and sit), and 
citrate uptake (fec). qPCR revealed notably increased expression of both the hem and fec uptake 
systems when sch was deleted, but with no exogenous heme added to the culture, citrate 
transport through the fec system was particularly interesting (Figure B.2). I then wondered why 
the Δsch and Δcbs/sch mutants displayed no CAS activity in M9 conditions if citrate was able to 
chelate (Figure 4.2). I made a stock solution of 10% sodium citrate and ran a standard curve of 
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citrate in the CAS assay to evaluate at what concentration citrate shows CAS activity. Minimal 
CAS activity was seen at 3.4 mM, whereas bacteria produce nanomolar concentrations of citrate; 
thus explaining why citrate was undetectable by CAS assay (Table B.1). Citrate is a weak iron 
chelator; however, when there is no competition for iron, I hypothesize that it can sufficiently 
transport enough iron for the bacterium. However, during mammalian infection or in a 
polymicrobial context when iron is bound in host proteins or other siderophores, Sm needs a 
siderophore with high iron affinity to effectively compete for nutrients. It is possible that citrate 







Figure B.1. The Dcbs and Dsch mutants grow comparably to WT in M9 minimal medium 
conditions. 
The indicated strains were grown in either chelex treated (iron removed) (A, C) or normal M9 
minimal medium (B, D). 36µM FeSO4 was added to the cultures where indicated (C, D). 
Cultures were incubated with aeration at 37˚C and OD600 readings were taken every 15 minutes 
to measure bacterial growth. 
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Figure B.2. Citrate transporter, fecA, is highly expressed in the absence of the 
serratiochelin locus, sch. 
Strains were grown to mid-log phase in M9 minimal medium when RNA was harvested. cDNA 
was synthesized and qPCR was performed to compare iron system expression when the 
siderophore loci were deleted. hem and has represent heme acquisition systems, sitB and efeO 
represent ferrous iron uptake systems, fecA represents citrate transport. cbsF and schF0 were 

































Table B.1. Iron chelation associated with increasing citrate concentration 
Citrate Concentration CAS Activity 
340 mM + 
3.4 mM +/- (minimal activity) 
34 µM - 
.34 µM - 

















The Role of Siderophores in UPEC Bacteremia 
 
Summary 
Uropathogenic E. coli (UPEC), the causative bacterium of most urinary tract infections 
(UTIs), encodes an arsenal of iron acquisition systems to import adequate iron for various 
cellular processes. Pyelonephritis E. coli strain CFT 073 encodes three siderophores 
(enterobactin, aerobactin, and salmochelin), two heme uptake systems, and 14 outer membrane 
transporters to bring in iron from these various sources. As such, these systems are redundant in 
their function, but potentially contribute unequally to UPEC virulence. For example, aerobactin 
and yersiniabactin mutants were frequently outcompeted in the urinary tract, and heme mutants 
were commonly outcompeted in the kidneys [19]. The importance of iron acquisition to UPEC 
has been well established in the context of UTIs with RNAseq experiments depicting significant 
upregulation of iron genes during active UTI [186]. However, if these UTIs are left untreated, 
bacteria can breach epithelial barriers in the urinary tract and infection can progress to the 
bloodstream. Almost 25% of sepsis cases occur from the urogenital tract, leading to mortality 
rates of 30-40% depending on the causative bacterium [187]. When infection reaches the 
bloodstream, it is unknown if a particular iron acquisition system is required for or contributes 
more significantly to establishing the infection.  
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In these experiments, asymptomatic bacteriuria strain ABU 83972 was used in addition to 
siderophore mutations made in CFT 073 and E. coli 536 to examine all siderophores in a 
common genetic background. CFT 073 and E. coli 536 express three of the four siderophores 
observed in UPEC strains; asymptomatic bacteriuria strains express all four siderophores 
although they do lack other UPEC virulence factors such as fimbriae [188]. The four 
siderophores of interest in this study and that UPEC strains can produce are the catecholate 
siderophores enterobactin and salmochelin, a hydroxamate aerobactin, and a mixed type 
siderophore called yersiniabactin. Enterobactin is produced and used by almost all E. coli strains; 
the host protein lipocalin-2 binds this molecule to inactivate it. Salmochelin is a glycosylated 
form of enterobactin and evades lipocalin-2 binding. Salmochelin, aerobactin, and yersiniabactin 
are considered stealth siderophores as they are typically found in pathogenic strains of E. coli.      
Previous literature has described the importance of noncatecholate siderophores to 
establishing UTIs [19]; however, it is not known if similar or differing siderophores are 
important once the infection reaches the bloodstream. Therefore, we hypothesized that much like 
in the urinary tract, specific siderophores have a more significant contribution to bloodstream 
colonization.  
This study used biosynthetic and receptor siderophore mutants in CFT 073, E. coli 536, 
and ABU 83972 in independent and mixed infections to determine if losing specific siderophore 
systems resulted in bacterial attenuation and/or a competitive disadvantage within the murine 
bloodstream. Initial experiments competing enterobactin, salmochelin, yersiniabactin, and 
aerobactin mutants against WT showed that an enterobactin biosynthesis mutant as well as 
yersiniabactin biosynthesis and receptor mutants had competitive disadvantages in the 
bloodstream (Figure C.1A, B). This suggests the importance of these siderophores during 
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infection. However, salmochelin and aerobactin mutants were equally as fit as the WT (Figure 
C.1C, D).   
Because most UPEC strains encode only three of the four siderophore operons, requiring 
the use of both CFT 073 and E. coli 536 to examine all four siderophores, I explored using ABU 
83972, a strain that encodes all siderophores, as a proxy for CFT 073 in order to evaluate all 
siderophores in one genetic background. I began by determining if the ABU strain could 
colonize the bloodstream to the same extent as CFT 073. Mice were independently challenged 
with either wild type CFT 073 or wild type ABU 83972. Infections were allowed to progress for 
one, two, and three days to determine an appropriate time point where CFT and ABU 
colonization levels were consistent. At one day post infection, the ABU strain colonized the 
bloodstream comparably to what was seen in the CFT infections in both the spleen and liver. 
Two days after the infection, bacterial counts between ABU and CFT were more variable and 
notably lower; however, not significantly different. Finally, after three days of infection, 
bacterial counts seemed to increase and were consistent between the ABU and CFT strains in 
both the spleen and liver (Figure C.2). Because bacterial counts were the most consistent 
between ABU 83972 and CFT 073 after one day, I proceeded with this time point for the 
following experiment.  
ABU 83972 was a suitable proxy to examine the role of all four siderophores in one 
genetic background because it colonized the bloodstream to the same extent as CFT 073. 
Therefore, ABU siderophore mutants were acquired from Mark Schembri at the University of 
Queensland [189]. These strains had mutations in the siderophore biosynthesis machinery and 
contained single, double, and triple knockouts of the siderophore systems giving every possible 
combination of siderophore expression. The mutants used are listed in Table C.1. The table also 
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denotes the functional siderophores still expressed after the mutations were made. In the spleen, 
the single mutants, including DybtS, DiroB, and DentB, colonized the bloodstream similar to wild 
type levels with only a small decrease seen in the single DiucABCD mutant. This suggests 
potential overlapping roles between the intact siderophores systems. The mutant DiucABCD/iroB 
which still produces enterobactin and yersiniabactin saw comparable levels of wild type 
colonization. Interestingly, the mutant that does not make either enterobactin or yersiniabactin, 
DentB/ybtS, performed the worst in the bloodstream. Mutants that were able to produce only 
enterobactin or yersiniabactin, DiucaABCD/iroB/ybtS and DentB/iucABCD, respectively, had 
similar bacterial counts to WT. The DiucABCD/ybtS mutant which still produces enterobactin as 
well as salmochelin along with the DiroB/ybtS mutant which makes enterobacin and aerobactin 
did struggle slightly in the spleen. Surprisingly, the strain that did not produce any siderophores, 
DentB/iucABCD/ybtS, was able to colonize the bloodstream comparably to WT, potentially 
suggesting the importance of heme uptake in this model (Figure C.3A). 
Similar trends seen in the spleen were also seen in the liver. The single mutants seemed 
to perform only slightly better than WT in the liver with the DiroB mutant doing the best. This 
may further emphasize the potential redundancy of the iron acquisition systems. In general, 
strains that produce either enterobactin, yersiniabactin, or both, performed as well as WT in the 
liver. The only mutant that didn’t follow this trend was DiucABCD/ybtS which still produces 
enterobactin, but had only a slight decrease in bacterial counts (Figure C.3B). Taken together, 
these results generally suggest that yersiniabactin and enterobactin contribute more so to 
pathogenesis in the bloodstream after one day of infection corroborating our earlier results in 
CFT073 and E. coli 536.  
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Particular mutants did show decreased colonization one day after infection; however, it is 
possible that bacteria rely on different siderophores at different points in the infection. Therefore, 
I looked at bloodstream colonization at 2- and 3-days post infection to determine if the same 
mutants were consistently showing decreased bacterial counts. The DentB/ybtS mutant had 
comparable colonization to the wild type on day 2; however, it had significantly decreased 
bacterial burden on day 3. This result is consistent with the colonization seen with 
DiucABCD/iroB on day 3, which has intact enterobactin and yersiniabactin. After having 
decreased colonization on day 2, the DiucABCD/iroB mutant rebounded to wild type levels on 
day 3, the same time point when the DentB/ybtS mutant severely struggled. This suggests that 
enterobactin and yersiniabactin together may also play a role later in the infection (Figure 
C.4A).  
In the liver, while the DiucABCD mutant did not show decreased colonization after one 
day, it had decreased bacterial burden two and three days after infection, consistent with what is 
seen in the spleen. The DybtS mutant had a similar level of colonization to wild type after two 
days; however, three days after infection, its bacterial burden dropped notably. DentB had 
consistently lower bacterial counts in the liver at 2 and 3 days post infection compared to WT 
while DiroB had levels comparable to WT. The DiucABCD/iroB and DiroB/ybtS mutants saw 
mild to moderate reduction in bacterial counts at two- and three-days post infection, which can 
be attributed to the loss of DiucABCD and DybtS, respectively, and not the loss of DiroB since the 
individual DiucABCD and DybtS single mutants had such notable decreases on their own and 
DiroB saw no such decrease alone (Figure C.4B).  
Similar to what was seen in the spleen, mutants lacking DentB and DybtS had decreased 
burdens at day three in the liver, further suggesting the importance of enterobactin and 
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yersiniabactin throughout the infection while aerobactin seems to be important at later time 
points (2 and 3 days post infection). Salmochelin does not seem to play a significant role. To 
conclude, mutants having a colonization defect at one time point didn’t necessarily have a defect 
at another time point, suggesting that particular siderophores may be important at different times 
during infections. Therefore, temporal requirement of individual siderophores may be necessary 



















Table C.1. Siderophore mutants in ABU 83972a 
Mutant Functional Siderophores 
WT  E Y S A 
ΔiucABCD E Y S 
ΔybtS E S A 
ΔiroB E Y A 
ΔentB Y A 
ΔiucABCD/iroB E Y 
ΔiroB/ybtS E A 





aMutants are single, double, and triple knockouts of the siderophore systems. Functional 
siderophores are those siderophores still expressed after mutation (E=enterobactin, 








Figure C.1. Enterobactin and yersiniabactin significantly contribute to UPEC bacteremia. 
CBA/J mice were co-challenged via the tail vein with a 1:1 ratio of WT E.coli and the 
siderophore biosynthesis/receptor mutant. At 24 hours post infection, liver and spleen were 

























































































































































































p = 0.0004 p = 0.0036





The solid black line represents a CI of 1.0, meaning the two strains compete equally. Solid red 
lines represent median CI. Statistics were calculated using the Wilcoxon Signed Rank Test with 
















Figure C.2. ABU 83972 colonizes the bloodstream comparably to CFT073. 
Mice were challenged independently with either CFT 073 or ABU 83972. After 1, 2, and 3 days 
post infection spleen and liver were collected. Recovered bacteria were counted to determine the 














































































































































































































































































Figure C.3. Yersiniabactin and various other siderophore mutants have decreased 
bloodstream colonization compared to wild type 24 hours post infection. 
Mice were infected with each listed ABU mutant independently via the tail vein. After 24 hours, 
spleen and liver were harvested and homogenized. Recovered bacteria were counted to 
































































































































































Figure C.4. Temporal differences in mutant colonization are seen at two and three days 
post infection. 
Mice were independently challenged with the indicated ABU mutants. Spleen and liver were 
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